ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||||||||||||||||||||
tamoxifen
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Actr1b | ARP1 actin-related protein 1 homolog B, centractin beta (yeast) |
|
decreases expression | ISO | 9 | 35,632,318 | 35,641,982 | RGD:6480464 | CTD | |
| G | Adam22 | ADAM metallopeptidase domain 22 |
|
decreases expression | ISO | 4 | 22,332,086 | 22,507,086 | RGD:6480464 | CTD | |
| G | Adat2 | adenosine deaminase, tRNA-specific 2 |
|
affects expression | ISO | 1 | 8,358,164 | 8,372,650 | RGD:6480464 | CTD | |
| G | Amz2 | archaelysin family metallopeptidase 2 |
|
affects expression | ISO | 10 | 98,889,302 | 98,899,839 | RGD:6480464 | CTD | |
| G | Anln | anillin, actin binding protein |
|
affects expression | ISO | 8 | 21,642,021 | 21,721,815 | RGD:6480464 | CTD | |
| G | Ap1m2 | adaptor-related protein complex 1, mu 2 subunit |
|
affects expression | ISO | 8 | 20,385,982 | 20,396,146 | RGD:6480464 | CTD | |
| G | Apex2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 |
|
increases expression | ISO | X | 39,811,484 | 39,832,225 | RGD:6480464 | CTD | |
| G | Apex2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 |
|
affects expression | ISO | X | 39,811,484 | 39,832,225 | RGD:6480464 | CTD | |
| G | Atp5o | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
affects expression | ISO | 11 | 31,914,320 | 31,920,632 | RGD:6480464 | CTD | |
| G | Bach2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
affects expression | ISO | 5 | 48,611,805 | 48,881,943 | RGD:6480464 | CTD | |
| G | Bach2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
|
decreases expression | ISO | 5 | 48,611,805 | 48,881,943 | RGD:6480464 | CTD | |
| G | Bmp2k | BMP-2 inducible kinase |
|
affects expression | ISO | 14 | 13,937,544 | 14,001,748 | RGD:6480464 | CTD | |
| G | Bmp2k | BMP-2 inducible kinase |
|
decreases expression | ISO | 14 | 13,937,544 | 14,001,748 | RGD:6480464 | CTD | |
| G | Cacna1s | calcium channel, voltage-dependent, L type, alpha 1S subunit | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Camk1d | calcium/calmodulin-dependent protein kinase ID |
|
affects expression | ISO | 17 | 83,649,720 | 84,061,160 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
affects expression | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
decreases expression | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
decreases expression | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
affects expression | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
affects localization | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
increases expression | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
decreases expression | EXP | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
decreases expression | EXP | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
increases expression | EXP | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd2 | cyclin D2 |
|
affects expression | ISO | 4 | 163,523,817 | 163,546,501 | RGD:6480464 | CTD | |
| G | Ccnd3 | cyclin D3 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Ccnd3 | cyclin D3 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Ccndbp1 | cyclin D-type binding-protein 1 |
|
affects expression | ISO | 3 | 107,787,374 | 107,800,798 | RGD:6480464 | CTD | |
| G | Ccne1 | cyclin E1 |
|
multiple interactions | ISO | 1 | 90,568,189 | 90,577,426 | RGD:6480464 | CTD | |
| G | Ccne1 | cyclin E1 |
|
affects response to substance | ISO | 1 | 90,568,189 | 90,577,426 | RGD:6480464 | CTD | |
| G | Ccne1 | cyclin E1 |
|
increases expression | ISO | 1 | 90,568,189 | 90,577,426 | RGD:6480464 | CTD | |
| G | Ccne1 | cyclin E1 |
|
increases expression | ISO | 1 | 90,568,189 | 90,577,426 | RGD:6480464 | CTD | |
| G | Ccne1 | cyclin E1 |
|
decreases expression | EXP | 1 | 90,568,189 | 90,577,426 | RGD:6480464 | CTD | |
| G | Ccng1 | cyclin G1 |
|
affects expression | ISO | 10 | 25,776,380 | 25,782,754 | RGD:6480464 | CTD | |
| G | Ccnl1 | cyclin L1 |
|
affects expression | ISO | 2 | 155,757,335 | 155,769,633 | RGD:6480464 | CTD | |
| G | Ccpg1 | cell cycle progression 1 |
|
affects expression | ISO | 8 | 77,724,315 | 77,768,060 | RGD:6480464 | CTD | |
| G | Ccrn4l | CCR4 carbon catabolite repression 4-like (S. cerevisiae) |
|
affects expression | ISO | 2 | 140,120,310 | 140,140,518 | RGD:6480464 | CTD | |
| G | Cct2 | chaperonin containing TCP1, subunit 2 (beta) |
|
affects expression | ISO | 7 | 56,391,341 | 56,404,084 | RGD:6480464 | CTD | |
| G | Cct3 | chaperonin containing Tcp1, subunit 3 (gamma) |
|
affects expression | ISO | 2 | 180,381,044 | 180,434,152 | RGD:6480464 | CTD | |
| G | Cct5 | chaperonin containing Tcp1, subunit 5 (epsilon) |
|
affects expression | ISO | 2 | 83,681,785 | 83,692,937 | RGD:6480464 | CTD | |
| G | Cct7 | chaperonin containing Tcp1, subunit 7 (eta) |
|
affects expression | ISO | 4 | 119,706,130 | 119,722,975 | RGD:6480464 | CTD | |
| G | Cct7 | chaperonin containing Tcp1, subunit 7 (eta) |
|
increases expression | EXP | 4 | 119,706,130 | 119,722,975 | RGD:6480464 | CTD | |
| G | Chac1 | ChaC, cation transport regulator homolog 1 (E. coli) |
|
affects expression | ISO | 3 | 105,869,762 | 105,873,332 | RGD:6480464 | CTD | |
| G | Chd1l | chromodomain helicase DNA binding protein 1-like |
|
affects expression | ISO | 2 | 192,382,644 | 192,438,157 | RGD:6480464 | CTD | |
| G | Chek1 | checkpoint kinase 1 |
|
affects expression | ISO | 8 | 37,954,322 | 37,974,748 | RGD:6480464 | CTD | |
| G | Chka | choline kinase alpha |
|
affects expression | ISO | 1 | 206,368,963 | 206,418,526 | RGD:6480464 | CTD | |
| G | Chmp2a | charged multivesicular body protein 2A |
|
affects expression | ISO | 1 | 72,889,349 | 72,891,734 | RGD:6480464 | CTD | |
| G | Chordc1 | cysteine and histidine-rich domain (CHORD)-containing 1 |
|
affects expression | ISO | 8 | 15,732,905 | 15,759,297 | RGD:6480464 | CTD | |
| G | Chrd | chordin |
|
affects expression | ISO | 11 | 82,401,701 | 82,410,401 | RGD:6480464 | CTD | |
| G | Chrna3 | cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
multiple interactions | ISO | 8 | 58,570,223 | 58,583,594 | RGD:6480464 | CTD | |
| G | Chrna4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions | ISO | 3 | 170,171,214 | 170,185,998 | RGD:6480464 | CTD | |
| G | Chrnb2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
multiple interactions | ISO | 2 | 181,961,373 | 181,969,581 | RGD:6480464 | CTD | |
| G | Chrnb4 | cholinergic receptor, nicotinic, beta 4 (neuronal) |
|
multiple interactions | ISO | 8 | 58,586,961 | 58,605,545 | RGD:6480464 | CTD | |
| G | Chst10 | carbohydrate sulfotransferase 10 |
|
affects expression | ISO | 9 | 37,851,796 | 37,881,657 | RGD:6480464 | CTD | |
| G | Chtf18 | CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
|
affects expression | ISO | 10 | 14,988,146 | 14,996,182 | RGD:6480464 | CTD | |
| G | Chuk | conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions | ISO | 1 | 249,122,845 | 249,158,369 | RGD:6480464 | CTD | |
| G | Cib1 | calcium and integrin binding 1 (calmyrin) |
|
affects expression | ISO | 1 | 136,031,865 | 136,045,153 | RGD:6480464 | CTD | |
| G | Cirbp | cold inducible RNA binding protein |
|
affects expression | ISO | 7 | 11,047,003 | 11,050,820 | RGD:6480464 | CTD | |
| G | Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
increases response to substance | ISO | 1 | 12,721,500 | 12,723,943 | RGD:6480464 | CTD | |
| G | Cited2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
affects expression | ISO | 1 | 12,721,500 | 12,723,943 | RGD:6480464 | CTD | |
| G | Ckb | creatine kinase, brain |
|
increases expression | EXP | 6 | 136,452,215 | 136,455,122 | RGD:6480464 | CTD | |
| G | Ckb | creatine kinase, brain |
|
multiple interactions | EXP | 6 | 136,452,215 | 136,455,122 | RGD:6480464 | CTD | |
| G | Ckb | creatine kinase, brain |
|
increases expression | ISO | 6 | 136,452,215 | 136,455,122 | RGD:6480464 | CTD | |
| G | Ckmt1b | creatine kinase, mitochondrial 1B |
|
affects expression | ISO | 3 | 108,158,887 | 108,163,888 | RGD:6480464 | CTD | |
| G | Cks1b | CDC28 protein kinase regulatory subunit 1B |
|
affects expression | ISO | 2 | 181,611,639 | 181,616,222 | RGD:6480464 | CTD | |
| G | Cks2 | CDC28 protein kinase regulatory subunit 2 |
|
affects expression | ISO | 17 | 19,423,502 | 19,429,451 | RGD:6480464 | CTD | |
| G | Clca1 | chloride channel accessory 1 |
|
affects expression | ISO | 2 | 243,057,135 | 243,084,146 | RGD:6480464 | CTD | |
| G | Clcn4 | chloride channel, voltage-sensitive 4 |
|
multiple interactions | ISO | X | 44,355,648 | 44,419,524 | RGD:6480464 | CTD | |
| G | Clcn4 | chloride channel, voltage-sensitive 4 |
|
affects expression | ISO | X | 44,355,648 | 44,419,524 | RGD:6480464 | CTD | |
| G | Cldn1 | claudin 1 |
|
affects expression | ISO | 11 | 76,473,654 | 76,488,809 | RGD:6480464 | CTD | |
| G | Cldn2 | claudin 2 |
|
affects expression | ISO | X | 127,538,685 | 127,549,019 | RGD:6480464 | CTD | |
| G | Cldn3 | claudin 3 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Cldn4 | claudin 4 |
|
affects response to substance | ISO | 12 | 22,816,134 | 22,817,932 | RGD:6480464 | CTD | |
| G | Clec2h | C-type lectin domain family 2, member H |
|
affects expression | ISO | 4 | 166,193,710 | 166,299,866 | RGD:6480464 | CTD | |
| G | Clic1 | chloride intracellular channel 1 |
|
affects expression | ISO | 20 | 3,498,935 | 3,842,500 | RGD:6480464 | CTD | |
| G | Clint1 | clathrin interactor 1 |
|
affects expression | ISO | 10 | 30,996,087 | 31,047,175 | RGD:6480464 | CTD | |
| G | Clk1 | CDC-like kinase 1 |
|
affects expression | ISO | 9 | 57,070,825 | 57,082,043 | RGD:6480464 | CTD | |
| G | Clock | clock circadian regulator |
|
affects expression | ISO | 14 | 34,218,472 | 34,258,054 | RGD:6480464 | CTD | |
| G | Clp1 | cleavage and polyadenylation factor I subunit 1 |
|
affects expression | ISO | 3 | 67,934,068 | 67,937,772 | RGD:6480464 | CTD | |
| G | Cltb | clathrin, light chain B |
|
affects expression | ISO | 17 | 16,063,715 | 16,081,277 | RGD:6480464 | CTD | |
| G | Cltc | clathrin, heavy chain (Hc) |
|
affects expression | ISO | 10 | 74,976,825 | 75,032,529 | RGD:6480464 | CTD | |
| G | Clu | clusterin |
|
decreases expression | ISO | 15 | 45,365,779 | 45,405,314 | RGD:6480464 | CTD | |
| G | Cml5 | camello-like 5 |
|
affects expression | ISO | 4 | 119,981,266 | 120,006,794 | RGD:6480464 | CTD | |
| G | Cmpk2 | cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
|
affects expression | ISO | 6 | 44,128,544 | 44,139,346 | RGD:6480464 | CTD | |
| G | Cnn1 | calponin 1, basic, smooth muscle |
|
affects expression | ISO | 8 | 21,210,524 | 21,221,024 | RGD:6480464 | CTD | |
| G | Cnot4 | CCR4-NOT transcription complex, subunit 4 |
|
increases expression | ISO | 4 | 62,437,688 | 62,548,524 | RGD:6480464 | CTD | |
| G | Cnot4 | CCR4-NOT transcription complex, subunit 4 |
|
increases expression | EXP | 4 | 62,437,688 | 62,548,524 | RGD:6480464 | CTD | |
| G | Cnot4 | CCR4-NOT transcription complex, subunit 4 |
|
affects expression | ISO | 4 | 62,437,688 | 62,548,524 | RGD:6480464 | CTD | |
| G | Col11a1 | collagen, type XI, alpha 1 |
|
affects expression | ISO | 2 | 209,996,467 | 210,193,379 | RGD:6480464 | CTD | |
| G | Col11a2 | collagen, type XI, alpha 2 |
|
increases expression | ISO | 20 | 4,924,452 | 4,953,310 | RGD:6480464 | CTD | |
| G | Col18a1 | collagen, type XVIII, alpha 1 |
|
affects expression | ISO | 20 | 11,920,816 | 11,982,468 | RGD:6480464 | CTD | |
| G | Col1a1 | collagen, type I, alpha 1 |
|
affects expression | ISO | 10 | 83,622,438 | 83,639,368 | RGD:6480464 | CTD | |
| G | Col4a1 | collagen, type IV, alpha 1 |
|
affects expression | ISO | 16 | 83,045,183 | 83,157,835 | RGD:6480464 | CTD | |
| G | Col5a1 | collagen, type V, alpha 1 |
|
affects expression | ISO | 3 | 6,826,169 | 6,971,054 | RGD:6480464 | CTD | |
| G | Col6a3 | collagen, type VI, alpha 3 |
|
affects expression | ISO | 9 | 89,990,129 | 90,043,697 | RGD:6480464 | CTD | |
| G | Col6a3 | collagen, type VI, alpha 3 |
|
affects expression | ISO | 9 | 89,990,129 | 90,043,697 | RGD:6480464 | CTD | |
| G | Commd3 | COMM domain containing 3 |
|
affects expression | ISO | 17 | 92,775,474 | 92,779,187 | RGD:6480464 | CTD | |
| G | Comt | catechol-O-methyltransferase |
|
affects expression | ISO | 11 | 84,561,591 | 84,581,713 | RGD:6480464 | CTD | |
| G | Comt | catechol-O-methyltransferase |
|
affects metabolic processing | ISO | 11 | 84,561,591 | 84,581,713 | RGD:6480464 | CTD | |
| G | Cope | coatomer protein complex, subunit epsilon |
|
affects expression | ISO | 16 | 19,602,842 | 19,609,515 | RGD:6480464 | CTD | |
| G | Cox5b | cytochrome c oxidase subunit Vb |
|
affects expression | ISO | 9 | 35,625,478 | 35,627,304 | RGD:6480464 | CTD | |
| G | Crispld2 | cysteine-rich secretory protein LCCL domain containing 2 |
|
multiple interactions | ISO | 19 | 50,313,710 | 50,378,031 | RGD:6480464 | CTD | |
| G | Crispld2 | cysteine-rich secretory protein LCCL domain containing 2 |
|
affects expression | ISO | 19 | 50,313,710 | 50,378,031 | RGD:6480464 | CTD | |
| G | Cyc1 | cytochrome c-1 |
|
affects expression | ISO | 7 | 114,394,178 | 114,396,563 | RGD:6480464 | CTD | |
| G | Cycs | cytochrome c, somatic |
|
affects expression | ISO | 4 | 78,825,878 | 78,827,978 | RGD:6480464 | CTD | |
| G | Cycs | cytochrome c, somatic |
|
increases expression | ISO | 4 | 78,825,878 | 78,827,978 | RGD:6480464 | CTD | |
| G | Cycs | cytochrome c, somatic |
|
increases expression | EXP | 4 | 78,825,878 | 78,827,978 | RGD:6480464 | CTD | |
| G | Cylc2 | cylicin, basic protein of sperm head cytoskeleton 2 |
|
increases expression | ISO | 5 | 68,005,845 | 68,020,150 | RGD:6480464 | CTD | |
| G | Cyp17a1 | cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
increases response to substance | ISO | 1 | 251,965,458 | 251,971,449 | RGD:6480464 | CTD | |
| G | Cyp17a1 | cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
affects expression | ISO | 1 | 251,965,458 | 251,971,449 | RGD:6480464 | CTD | |
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression | EXP | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a2 | cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases hydroxylation | EXP | 8 | 61,439,062 | 61,447,861 | RGD:6480464 | CTD | |
| G | Cyp1b1 | cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression | ISO | 6 | 2,548,224 | 2,553,767 | RGD:6480464 | CTD | |
| G | Cyp1b1 | cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases activity | ISO | 6 | 2,548,224 | 2,553,767 | RGD:6480464 | CTD | |
| G | Cyp21a1 | cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
affects expression | ISO | 20 | 4,125,357 | 4,128,518 | RGD:6480464 | CTD | |
| G | Cyp24a1 | cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 3 | 161,542,131 | 161,553,801 | RGD:6480464 | CTD | |
| G | Cyp26a1 | cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
affects expression | ISO | 1 | 241,945,472 | 241,949,220 | RGD:6480464 | CTD | |
| G | Cyp26a1 | cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
affects expression | ISO | 1 | 241,945,472 | 241,949,220 | RGD:6480464 | CTD | |
| G | Cyp26b1 | cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
multiple interactions | ISO | 4 | 118,734,786 | 118,751,606 | RGD:6480464 | CTD | |
| G | Cyp27b1 | cytochrome P450, family 27, subfamily b, polypeptide 1 | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cyp2a3 | cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases expression | ISO | 1 | 81,944,896 | 81,953,007 | RGD:6480464 | CTD | |
| G | Cyp2b1 | cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
affects expression | ISO | 1 | 81,266,828 | 81,290,471 | RGD:6480464 | CTD | |
| G | Cyp2b2 | cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression | EXP | 1 | 81,345,425 | 81,359,415 | RGD:6480464 | CTD | |
| G | Cyp2b2 | cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression | ISO | 1 | 81,345,425 | 81,359,415 | RGD:6480464 | CTD | |
| G | Cyp2c11 | cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions | EXP | 1 | 243,281,320 | 243,320,945 | RGD:6480464 | CTD | |
| G | Cyp2c79 | cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
decreases activity | ISO | 1 | 244,400,004 | 244,493,624 | RGD:6480464 | CTD | |
| G | Cyp2d3 | cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
affects response to substance | ISO | 7 | 120,778,783 | 120,783,140 | RGD:6480464 | CTD | |
| G | Cyp2d3 | cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
decreases response to substance | ISO | 7 | 120,778,783 | 120,783,140 | RGD:6480464 | CTD | |
| G | Cyp2d4 | cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
multiple interactions | ISO | 7 | 120,742,273 | 120,752,274 | RGD:6480464 | CTD | |
| G | Cyp2d4 | cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
affects response to substance | ISO | 7 | 120,742,273 | 120,752,274 | RGD:6480464 | CTD | |
| G | Cyp2d4 | cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
decreases response to substance | ISO | 7 | 120,742,273 | 120,752,274 | RGD:6480464 | CTD | |
| G | Cyp2d4 | cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
increases response to substance | ISO | 7 | 120,742,273 | 120,752,274 | RGD:6480464 | CTD | |
| G | Cyp2d4 | cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
affects metabolic processing | ISO | 7 | 120,742,273 | 120,752,274 | RGD:6480464 | CTD | |
| G | Cyp2d4 | cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
increases metabolic processing | ISO | 7 | 120,742,273 | 120,752,274 | RGD:6480464 | CTD | |
| G | Cyp2d4 | cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
increases response to substance | ISO | 7 | 120,742,273 | 120,752,274 | RGD:6480464 | CTD | |
| G | Cyp2d4 | cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
increases expression | ISO | 7 | 120,742,273 | 120,752,274 | RGD:6480464 | CTD | |
| G | Cyp2s1 | cytochrome P450, family 2, subfamily s, polypeptide 1 |
|
affects expression | ISO | 1 | 81,008,464 | 81,023,486 | RGD:6480464 | CTD | |
| G | Cyp3a2 | cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases hydroxylation | EXP | 12 | 9,517,016 | 9,541,000 | RGD:6480464 | CTD | |
| G | Cyp3a2 | cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions | EXP | 12 | 9,517,016 | 9,541,000 | RGD:6480464 | CTD | |
| G | Cyp3a2 | cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases metabolic processing | ISO | 12 | 9,517,016 | 9,541,000 | RGD:6480464 | CTD | |
| G | Cyp3a2 | cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions | ISO | 12 | 9,517,016 | 9,541,000 | RGD:6480464 | CTD | |
| G | Cyp3a2 | cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity | ISO | 12 | 9,517,016 | 9,541,000 | RGD:6480464 | CTD | |
| G | Cyp3a2 | cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression | ISO | 12 | 9,517,016 | 9,541,000 | RGD:6480464 | CTD | |
| G | Cyp3a2 | cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions | ISO | 12 | 9,517,016 | 9,541,000 | RGD:6480464 | CTD | |
| G | Cyp3a9 | cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
affects metabolic processing | ISO | 12 | 17,164,384 | 17,204,589 | RGD:6480464 | CTD | |
| G | Cyp3a9 | cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
decreases activity | ISO | 12 | 17,164,384 | 17,204,589 | RGD:6480464 | CTD | |
| G | Cyp4a8 | cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
decreases expression | EXP | 5 | 135,546,858 | 135,578,199 | RGD:6480464 | CTD | |
| G | Cyp4b1 | cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
affects expression | ISO | 5 | 135,917,327 | 135,934,636 | RGD:6480464 | CTD | |
| G | Cyp4f4 | cytochrome P450, family 4, subfamily f, polypeptide 4 |
|
affects expression | ISO | 7 | 13,293,080 | 13,309,416 | RGD:6480464 | CTD | |
| G | Cyp51 | cytochrome P450, family 51 |
|
affects expression | ISO | 4 | 26,752,677 | 26,771,131 | RGD:6480464 | CTD | |
| G | Cyp7a1 | cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
decreases expression | EXP | 5 | 19,707,159 | 19,716,856 | RGD:6480464 | CTD | |
| G | Cyp7a1 | cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
affects expression | ISO | 5 | 19,707,159 | 19,716,856 | RGD:6480464 | CTD | |
| G | Cyp7b1 | cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
affects expression | ISO | 2 | 103,102,679 | 103,271,273 | RGD:6480464 | CTD | |
| G | Cyr61 | cysteine-rich, angiogenic inducer, 61 |
|
affects expression | ISO | 2 | 243,824,303 | 243,827,262 | RGD:6480464 | CTD | |
| G | Cys1 | cystin 1 |
|
affects expression | ISO | 6 | 42,311,213 | 42,328,045 | RGD:6480464 | CTD | |
| G | Cysltr2 | cysteinyl leukotriene receptor 2 |
|
affects expression | ISO | 15 | 53,647,500 | 53,648,429 | RGD:6480464 | CTD | |
| G | Dact1 | dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) |
|
multiple interactions | ISO | 6 | 93,402,304 | 93,411,668 | RGD:6480464 | CTD | |
| G | Ddx3y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked |
|
affects expression | ISO | X | 21,498,202 | 21,505,416 | RGD:6480464 | CTD | |
| G | Desi1 | desumoylating isopeptidase 1 |
|
affects expression | ISO | 7 | 120,380,505 | 120,401,688 | RGD:6480464 | CTD | |
| G | Dpagt1 | dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) |
|
affects expression | ISO | 8 | 47,305,087 | 47,311,488 | RGD:6480464 | CTD | |
| G | Dpf1 | D4, zinc and double PHD fingers family 1 |
|
affects expression | ISO | 1 | 84,444,143 | 84,452,889 | RGD:6480464 | CTD | |
| G | Drd5 | dopamine receptor D5 |
|
affects expression | ISO | 14 | 77,768,060 | 77,769,487 | RGD:6480464 | CTD | |
| G | Drd5 | dopamine receptor D5 |
|
increases expression | ISO | 14 | 77,768,060 | 77,769,487 | RGD:6480464 | CTD | |
| G | Drg2 | developmentally regulated GTP binding protein 2 |
|
affects expression | ISO | 10 | 46,718,753 | 46,732,841 | RGD:6480464 | CTD | |
| G | Dsc2 | desmocollin 2 |
|
affects expression | ISO | 18 | 11,902,185 | 11,933,989 | RGD:6480464 | CTD | |
| G | Dst | dystonin |
|
affects expression | ISO | 9 | 32,757,554 | 33,051,275 | RGD:6480464 | CTD | |
| G | Dst | dystonin |
|
increases expression | ISO | 9 | 32,757,554 | 33,051,275 | RGD:6480464 | CTD | |
| G | Dtnb | dystrobrevin, beta |
|
affects expression | ISO | 6 | 26,542,148 | 26,742,199 | RGD:6480464 | CTD | |
| G | Dtnbp1 | dystrobrevin binding protein 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Dus2l | dihydrouridine synthase 2-like, SMM1 homolog (S. cerevisiae) |
|
affects expression | ISO | 19 | 35,858,496 | 35,901,661 | RGD:6480464 | CTD | |
| G | Dus3l | dihydrouridine synthase 3-like (S. cerevisiae) | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Dusp1 | dual specificity phosphatase 1 |
|
affects expression | ISO | 10 | 16,942,913 | 16,945,696 | RGD:6480464 | CTD | |
| G | Dusp1 | dual specificity phosphatase 1 |
|
affects expression | ISO | 10 | 16,942,913 | 16,945,696 | RGD:6480464 | CTD | |
| G | Dusp2 | dual specificity phosphatase 2 |
|
multiple interactions | ISO | 3 | 114,838,605 | 114,840,790 | RGD:6480464 | CTD | |
| G | Dusp5 | dual specificity phosphatase 5 |
|
increases expression | ISO | 1 | 259,754,234 | 259,767,645 | RGD:6480464 | CTD | |
| G | Dusp5 | dual specificity phosphatase 5 |
|
multiple interactions | ISO | 1 | 259,754,234 | 259,767,645 | RGD:6480464 | CTD | |
| G | Dvl2 | dishevelled, dsh homolog 2 (Drosophila) | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Dynll1 | dynein light chain LC8-type 1 |
|
affects expression | ISO | 12 | 42,580,542 | 42,582,915 | RGD:6480464 | CTD | |
| G | Dynll1 | dynein light chain LC8-type 1 |
|
increases expression | ISO | 12 | 42,580,542 | 42,582,915 | RGD:6480464 | CTD | |
| G | Dynll1 | dynein light chain LC8-type 1 |
|
increases expression | EXP | 12 | 42,580,542 | 42,582,915 | RGD:6480464 | CTD | |
| G | Dynlrb2 | dynein light chain roadblock-type 2 |
|
affects expression | ISO | 19 | 46,546,841 | 46,559,015 | RGD:6480464 | CTD | |
| G | E2f1 | E2F transcription factor 1 |
|
multiple interactions | ISO | 3 | 145,032,489 | 145,043,729 | RGD:6480464 | CTD | |
| G | E2f1 | E2F transcription factor 1 |
|
decreases expression | ISO | 3 | 145,032,489 | 145,043,729 | RGD:6480464 | CTD | |
| G | E2f1 | E2F transcription factor 1 |
|
increases expression | ISO | 3 | 145,032,489 | 145,043,729 | RGD:6480464 | CTD | |
| G | E2f1 | E2F transcription factor 1 |
|
multiple interactions | EXP | 3 | 145,032,489 | 145,043,729 | RGD:6480464 | CTD | |
| G | E2f1 | E2F transcription factor 1 |
|
decreases expression | EXP | 3 | 145,032,489 | 145,043,729 | RGD:6480464 | CTD | |
| G | E2f6 | E2F transcription factor 6 |
|
affects expression | ISO | 6 | 40,494,286 | 40,534,152 | RGD:6480464 | CTD | |
| G | E2f8 | E2F transcription factor 8 |
|
affects expression | ISO | 1 | 98,640,381 | 98,694,764 | RGD:6480464 | CTD | |
| G | E4f1 | E4F transcription factor 1 |
|
affects expression | ISO | 10 | 13,701,558 | 13,713,008 | RGD:6480464 | CTD | |
| G | Ebi3 | Epstein-Barr virus induced 3 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Ebp | emopamil binding protein (sterol isomerase) |
|
affects expression | ISO | X | 26,331,199 | 26,337,542 | RGD:6480464 | CTD | |
| G | Ece1 | endothelin converting enzyme 1 |
|
multiple interactions | ISO | 5 | 156,635,656 | 156,735,783 | RGD:6480464 | CTD | |
| G | Ece1 | endothelin converting enzyme 1 |
|
increases expression | ISO | 5 | 156,635,656 | 156,735,783 | RGD:6480464 | CTD | |
| G | Ece2 | endothelin-converting enzyme 2 |
|
affects expression | ISO | 11 | 82,492,975 | 82,507,876 | RGD:6480464 | CTD | |
| G | Edc3 | enhancer of mRNA decapping 3 homolog (S. cerevisiae) |
|
affects expression | ISO | 8 | 61,472,266 | 61,517,590 | RGD:6480464 | CTD | |
| G | Edem1 | ER degradation enhancer, mannosidase alpha-like 1 |
|
affects expression | ISO | 4 | 144,349,966 | 144,379,501 | RGD:6480464 | CTD | |
| G | Edn1 | endothelin 1 |
|
multiple interactions | ISO | 17 | 28,303,886 | 28,309,775 | RGD:6480464 | CTD | |
| G | Edn1 | endothelin 1 |
|
increases expression | ISO | 17 | 28,303,886 | 28,309,775 | RGD:6480464 | CTD | |
| G | Edn1 | endothelin 1 |
|
affects expression | ISO | 17 | 28,303,886 | 28,309,775 | RGD:6480464 | CTD | |
| G | Ednra | endothelin receptor type A |
|
multiple interactions | ISO | 19 | 32,042,366 | 32,108,153 | RGD:6480464 | CTD | |
| G | Ednra | endothelin receptor type A |
|
multiple interactions | ISO | 19 | 32,042,366 | 32,108,153 | RGD:6480464 | CTD | |
| G | Ednra | endothelin receptor type A |
|
increases expression | ISO | 19 | 32,042,366 | 32,108,153 | RGD:6480464 | CTD | |
| G | Eef1a1 | eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression | ISO | 8 | 83,463,591 | 83,466,813 | RGD:6480464 | CTD | |
| G | Eef1a1 | eukaryotic translation elongation factor 1 alpha 1 |
|
multiple interactions | ISO | 8 | 83,463,591 | 83,466,813 | RGD:6480464 | CTD | |
| G | Eef1g | eukaryotic translation elongation factor 1 gamma |
|
affects expression | ISO | 1 | 211,640,954 | 211,651,560 | RGD:6480464 | CTD | |
| G | Eef2k | eukaryotic elongation factor-2 kinase |
|
affects expression | ISO | 1 | 179,712,404 | 179,754,345 | RGD:6480464 | CTD | |
| G | Eepd1 | endonuclease/exonuclease/phosphatase family domain containing 1 |
|
affects expression | ISO | 8 | 25,173,429 | 25,286,246 | RGD:6480464 | CTD | |
| G | Efemp1 | EGF-containing fibulin-like extracellular matrix protein 1 |
|
affects expression | ISO | 14 | 109,733,625 | 109,828,630 | RGD:6480464 | CTD | |
| G | Efhd1 | EF-hand domain family, member D1 |
|
affects expression | ISO | 9 | 86,076,009 | 86,124,552 | RGD:6480464 | CTD | |
| G | Efna1 | ephrin A1 |
|
affects expression | ISO | 2 | 181,444,599 | 181,451,944 | RGD:6480464 | CTD | |
| G | Efnb3 | ephrin B3 |
|
affects expression | ISO | 10 | 56,373,322 | 56,379,316 | RGD:6480464 | CTD | |
| G | Eftud2 | elongation factor Tu GTP binding domain containing 2 |
|
affects expression | ISO | 10 | 92,012,161 | 92,053,043 | RGD:6480464 | CTD | |
| G | Eif1 | eukaryotic translation initiation factor 1 |
|
increases expression | ISO | 10 | 89,255,637 | 89,257,728 | RGD:6480464 | CTD | |
| G | Eif1l1 | eukaryotic translation initiation factor 1-like 1 |
|
multiple interactions | ISO | 5 | 21,736,137 | 21,736,478 | RGD:6480464 | CTD | |
| G | Eif1l1 | eukaryotic translation initiation factor 1-like 1 |
|
increases expression | ISO | 5 | 21,736,137 | 21,736,478 | RGD:6480464 | CTD | |
| G | Eif1l1 | eukaryotic translation initiation factor 1-like 1 |
|
increases expression | EXP | 5 | 21,736,137 | 21,736,478 | RGD:6480464 | CTD | |
| G | Endod1 | endonuclease domain containing 1 |
|
multiple interactions | ISO | 8 | 11,151,051 | 11,180,463 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects response to substance | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
increases response to substance | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
decreases response to substance | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
increases response to substance | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects activity | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects expression | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects methylation | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Ext2 | exostosin glycosyltransferase 2 |
|
affects expression | ISO | 3 | 78,111,436 | 78,244,444 | RGD:6480464 | CTD | |
| G | F3 | coagulation factor III (thromboplastin, tissue factor) |
|
affects expression | ISO | 2 | 218,371,050 | 218,382,645 | RGD:6480464 | CTD | |
| G | F7 | coagulation factor VII (serum prothrombin conversion accelerator) |
|
affects expression | ISO | 16 | 81,348,678 | 81,358,991 | RGD:6480464 | CTD | |
| G | F8 | coagulation factor VIII, procoagulant component |
|
affects expression | ISO | 18 | 121,134 | 162,008 | RGD:6480464 | CTD | |
| G | F8 | coagulation factor VIII, procoagulant component |
|
increases expression | ISO | 18 | 121,134 | 162,008 | RGD:6480464 | CTD | |
| G | F9 | coagulation factor IX |
|
increases expression | ISO | X | 145,527,978 | 145,575,966 | RGD:6480464 | CTD | |
| G | Fabp1 | fatty acid binding protein 1, liver |
|
increases expression | ISO | 4 | 104,412,200 | 104,415,981 | RGD:6480464 | CTD | |
| G | Fabp1 | fatty acid binding protein 1, liver |
|
decreases expression | EXP | 4 | 104,412,200 | 104,415,981 | RGD:6480464 | CTD | |
| G | Fabp3 | fatty acid binding protein 3, muscle and heart |
|
affects expression | ISO | 5 | 149,340,525 | 149,347,268 | RGD:6480464 | CTD | |
| G | Fabp7 | fatty acid binding protein 7, brain |
|
affects expression | ISO | 20 | 36,812,518 | 36,816,050 | RGD:6480464 | CTD | |
| G | Fadd | Fas (TNFRSF6)-associated via death domain |
|
multiple interactions | ISO | 1 | 205,010,363 | 205,012,768 | RGD:6480464 | CTD | |
| G | Fadd | Fas (TNFRSF6)-associated via death domain |
|
increases phosphorylation | ISO | 1 | 205,010,363 | 205,012,768 | RGD:6480464 | CTD | |
| G | Fads1 | fatty acid desaturase 1 |
|
affects expression | ISO | 1 | 212,670,792 | 212,685,718 | RGD:6480464 | CTD | |
| G | Fahd1 | fumarylacetoacetate hydrolase domain containing 1 |
|
affects expression | ISO | 10 | 14,101,624 | 14,103,063 | RGD:6480464 | CTD | |
| G | Fam107b | family with sequence similarity 107, member B |
|
affects expression | ISO | 17 | 85,593,001 | 85,663,908 | RGD:6480464 | CTD | |
| G | Fam110a | family with sequence similarity 110, member A |
|
affects expression | ISO | 3 | 142,326,013 | 142,328,572 | RGD:6480464 | CTD | |
| G | Fam110b | family with sequence similarity 110, member B |
|
decreases expression | ISO | 5 | 19,260,484 | 19,262,132 | RGD:6480464 | CTD | |
| G | Fam120b | family with sequence similarity 120B |
|
affects expression | ISO | 1 | 54,267,141 | 54,311,423 | RGD:6480464 | CTD | |
| G | Fam126a | family with sequence similarity 126, member A |
|
affects expression | ISO | 4 | 6,500,425 | 6,559,978 | RGD:6480464 | CTD | |
| G | Fam134b | family with sequence similarity 134, member B |
|
multiple interactions | ISO | 2 | 77,470,558 | 77,566,123 | RGD:6480464 | CTD | |
| G | Fam134b | family with sequence similarity 134, member B |
|
affects expression | ISO | 2 | 77,470,558 | 77,566,123 | RGD:6480464 | CTD | |
| G | Fam175b | family with sequence similarity 175, member B |
|
increases expression | ISO | 1 | 192,327,136 | 192,352,712 | RGD:6480464 | CTD | |
| G | Fam65b | family with sequence similarity 65, member B |
|
multiple interactions | ISO | 17 | 47,394,370 | 47,492,203 | RGD:6480464 | CTD | |
| G | Fancc | Fanconi anemia, complementation group C |
|
affects expression | ISO | 17 | 7,254,528 | 7,341,500 | RGD:6480464 | CTD | |
| G | Fap | fibroblast activation protein, alpha |
|
affects expression | ISO | 3 | 44,457,151 | 44,525,602 | RGD:6480464 | CTD | |
| G | Fars2 | phenylalanyl-tRNA synthetase 2, mitochondrial |
|
affects expression | ISO | 17 | 34,595,255 | 35,048,596 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
multiple interactions | EXP | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
multiple interactions | ISO | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
increases expression | ISO | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
decreases expression | ISO | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
increases expression | ISO | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Faslg | Fas ligand (TNF superfamily, member 6) |
|
increases expression | ISO | 13 | 77,472,950 | 77,480,210 | RGD:6480464 | CTD | |
| G | Fasn | fatty acid synthase | decreases expression | EXP | RGD:6480464 | CTD | |||||
| G | Fbln2 | fibulin 2 |
|
affects expression | ISO | 4 | 125,380,549 | 125,441,079 | RGD:6480464 | CTD | |
| G | Fbln5 | fibulin 5 |
|
affects expression | ISO | 6 | 126,018,541 | 126,098,234 | RGD:6480464 | CTD | |
| G | Fbxl12 | F-box and leucine-rich repeat protein 12 |
|
affects expression | ISO | 8 | 19,656,937 | 19,661,560 | RGD:6480464 | CTD | |
| G | Fbxl3 | F-box and leucine-rich repeat protein 3 |
|
affects expression | ISO | 15 | 87,093,141 | 87,113,003 | RGD:6480464 | CTD | |
| G | Fbxo11 | F-box protein 11 |
|
affects expression | ISO | 6 | 11,542,561 | 11,566,829 | RGD:6480464 | CTD | |
| G | Fbxo18 | F-box protein, helicase, 18 |
|
affects expression | ISO | 17 | 77,945,025 | 77,982,314 | RGD:6480464 | CTD | |
| G | Fbxo21 | F-box protein 21 |
|
affects expression | ISO | 12 | 39,719,654 | 39,753,892 | RGD:6480464 | CTD | |
| G | Fbxw11 | F-box and WD repeat domain containing 11 |
|
affects expression | ISO | 10 | 17,502,480 | 17,600,199 | RGD:6480464 | CTD | |
| G | Fbxw4 | F-box and WD repeat domain containing 4 |
|
affects expression | ISO | 1 | 250,746,869 | 250,874,460 | RGD:6480464 | CTD | |
| G | Fen1 | flap structure-specific endonuclease 1 |
|
affects expression | ISO | 1 | 212,688,118 | 212,692,486 | RGD:6480464 | CTD | |
| G | Fgd4 | FYVE, RhoGEF and PH domain containing 4 |
|
affects expression | ISO | 11 | 86,700,118 | 86,767,928 | RGD:6480464 | CTD | |
| G | Fgd6 | FYVE, RhoGEF and PH domain containing 6 |
|
multiple interactions | ISO | 7 | 31,160,021 | 31,286,379 | RGD:6480464 | CTD | |
| G | Fgf2 | fibroblast growth factor 2 |
|
decreases response to substance | ISO | 2 | 123,893,314 | 123,947,136 | RGD:6480464 | CTD | |
| G | Fgf2 | fibroblast growth factor 2 |
|
multiple interactions | ISO | 2 | 123,893,314 | 123,947,136 | RGD:6480464 | CTD | |
| G | Fgf21 | fibroblast growth factor 21 |
|
affects expression | ISO | 1 | 96,082,475 | 96,083,718 | RGD:6480464 | CTD | |
| G | Fgf7 | fibroblast growth factor 7 |
|
decreases response to substance | ISO | 3 | 113,468,427 | 113,517,538 | RGD:6480464 | CTD | |
| G | Fgf7 | fibroblast growth factor 7 |
|
multiple interactions | ISO | 3 | 113,468,427 | 113,517,538 | RGD:6480464 | CTD | |
| G | Fgfr1 | Fibroblast growth factor receptor 1 |
|
decreases response to substance | ISO | 16 | 70,869,974 | 70,910,045 | RGD:6480464 | CTD | |
| G | Fgfr1op2 | FGFR1 oncogene partner 2 |
|
affects expression | ISO | 4 | 184,153,022 | 184,173,961 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
multiple interactions | ISO | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
multiple interactions | ISO | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Foxc1 | forkhead box C1 |
|
affects expression | ISO | 17 | 39,026,186 | 39,030,163 | RGD:6480464 | CTD | |
| G | Fubp1 | far upstream element (FUSE) binding protein 1 |
|
affects expression | ISO | 2 | 250,749,095 | 250,777,521 | RGD:6480464 | CTD | |
| G | Gadd45g | growth arrest and DNA-damage-inducible, gamma |
|
affects expression | ISO | 17 | 19,230,896 | 19,232,641 | RGD:6480464 | CTD | |
| G | Gal | galanin/GMAP prepropeptide |
|
decreases expression | ISO | 1 | 205,936,352 | 205,941,215 | RGD:6480464 | CTD | |
| G | Galc | galactosylceramidase |
|
affects expression | ISO | 6 | 122,355,659 | 122,416,986 | RGD:6480464 | CTD | |
| G | Galns | galactosamine (N-acetyl)-6-sulfate sulfatase |
|
affects expression | ISO | 19 | 52,859,282 | 52,890,422 | RGD:6480464 | CTD | |
| G | Galnt2 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
|
affects expression | ISO | 19 | 54,479,961 | 54,529,837 | RGD:6480464 | CTD | |
| G | Galnt3 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
|
affects expression | ISO | 3 | 48,026,128 | 48,049,883 | RGD:6480464 | CTD | |
| G | Galt | galactose-1-phosphate uridylyltransferase |
|
affects expression | ISO | 5 | 59,185,418 | 59,188,642 | RGD:6480464 | CTD | |
| G | Galt | galactose-1-phosphate uridylyltransferase |
|
affects expression | ISO | 5 | 59,185,418 | 59,188,642 | RGD:6480464 | CTD | |
| G | Ganab | glucosidase, alpha; neutral AB |
|
affects expression | ISO | 1 | 211,573,299 | 211,593,941 | RGD:6480464 | CTD | |
| G | Gart | phosphoribosylglycinamide formyltransferase |
|
affects expression | ISO | 11 | 31,594,859 | 31,620,110 | RGD:6480464 | CTD | |
| G | Gas6 | growth arrest specific 6 |
|
multiple interactions | ISO | 16 | 80,900,159 | 80,930,929 | RGD:6480464 | CTD | |
| G | Gas6 | growth arrest specific 6 |
|
increases expression | ISO | 16 | 80,900,159 | 80,930,929 | RGD:6480464 | CTD | |
| G | Gata2 | GATA binding protein 2 |
|
affects expression | ISO | 4 | 122,279,753 | 122,288,528 | RGD:6480464 | CTD | |
| G | Gata2 | GATA binding protein 2 |
|
affects expression | ISO | 4 | 122,279,753 | 122,288,528 | RGD:6480464 | CTD | |
| G | Gata3 | GATA binding protein 3 |
|
increases expression | ISO | 17 | 79,991,587 | 80,011,574 | RGD:6480464 | CTD | |
| G | Gata3 | GATA binding protein 3 |
|
multiple interactions | ISO | 17 | 79,991,587 | 80,011,574 | RGD:6480464 | CTD | |
| G | Gatm | glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
affects expression | ISO | 3 | 109,558,043 | 109,565,432 | RGD:6480464 | CTD | |
| G | Gbp4 | guanylate binding protein 4 |
|
affects expression | ISO | 2 | 240,495,963 | 240,509,393 | RGD:6480464 | CTD | |
| G | Gca | grancalcin |
|
affects expression | ISO | 3 | 44,616,037 | 44,648,897 | RGD:6480464 | CTD | |
| G | Gck | glucokinase |
|
affects expression | ISO | 14 | 86,572,518 | 86,587,723 | RGD:6480464 | CTD | |
| G | Gclc | glutamate-cysteine ligase, catalytic subunit |
|
affects expression | ISO | 8 | 82,724,429 | 82,762,848 | RGD:6480464 | CTD | |
| G | Gdf10 | growth differentiation factor 10 |
|
affects expression | ISO | 16 | 9,558,781 | 9,570,656 | RGD:6480464 | CTD | |
| G | Gdf15 | growth differentiation factor 15 |
|
affects expression | ISO | 16 | 19,310,882 | 19,313,465 | RGD:6480464 | CTD | |
| G | Gdf3 | growth differentiation factor 3 |
|
affects expression | ISO | 4 | 159,064,054 | 159,067,854 | RGD:6480464 | CTD | |
| G | Gdpd3 | glycerophosphodiester phosphodiesterase domain containing 3 |
|
increases expression | ISO | 1 | 185,941,893 | 185,984,348 | RGD:6480464 | CTD | |
| G | Gfap | glial fibrillary acidic protein |
|
affects expression | ISO | 10 | 92,059,881 | 92,068,555 | RGD:6480464 | CTD | |
| G | Gfap | glial fibrillary acidic protein |
|
multiple interactions | ISO | 10 | 92,059,881 | 92,068,555 | RGD:6480464 | CTD | |
| G | Gfi1 | growth factor independent 1 transcription repressor |
|
increases expression | ISO | 14 | 2,597,303 | 2,606,681 | RGD:6480464 | CTD | |
| G | Gfm1 | G elongation factor, mitochondrial 1 |
|
affects expression | ISO | 2 | 157,283,046 | 157,327,969 | RGD:6480464 | CTD | |
| G | Gfpt1 | glutamine fructose-6-phosphate transaminase 1 |
|
increases expression | ISO | 4 | 121,204,274 | 121,250,160 | RGD:6480464 | CTD | |
| G | Gga3 | golgi associated, gamma adaptin ear containing, ARF binding protein 3 |
|
affects expression | ISO | 10 | 105,665,476 | 105,684,513 | RGD:6480464 | CTD | |
| G | Gh1 | growth hormone 1 |
|
decreases secretion | EXP | 10 | 95,692,240 | 95,694,117 | RGD:6480464 | CTD | |
| G | Gh1 | growth hormone 1 |
|
multiple interactions | EXP | 10 | 95,692,240 | 95,694,117 | RGD:6480464 | CTD | |
| G | Ghitm | growth hormone inducible transmembrane protein |
|
affects expression | ISO | 16 | 13,327,337 | 13,338,420 | RGD:6480464 | CTD | |
| G | Ghr | growth hormone receptor |
|
affects expression | ISO | 2 | 52,496,517 | 52,658,066 | RGD:6480464 | CTD | |
| G | Gip | gastric inhibitory polypeptide |
|
increases expression | ISO | 10 | 84,732,705 | 84,740,801 | RGD:6480464 | CTD | |
| G | Git2 | G protein-coupled receptor kinase interacting ArfGAP 2 |
|
affects expression | ISO | 12 | 43,117,706 | 43,158,710 | RGD:6480464 | CTD | |
| G | Gja1 | gap junction protein, alpha 1 |
|
affects expression | ISO | 20 | 35,409,815 | 35,422,262 | RGD:6480464 | CTD | |
| G | Gja1 | gap junction protein, alpha 1 |
|
affects expression | ISO | 20 | 35,409,815 | 35,422,262 | RGD:6480464 | CTD | |
| G | Gja1 | gap junction protein, alpha 1 |
|
multiple interactions | EXP | 20 | 35,409,815 | 35,422,262 | RGD:6480464 | CTD | |
| G | Gjb1 | gap junction protein, beta 1 |
|
multiple interactions | EXP | X | 89,448,873 | 89,456,812 | RGD:6480464 | CTD | |
| G | Gjb2 | gap junction protein, beta 2 |
|
increases expression | ISO | 15 | 36,153,526 | 36,159,490 | RGD:6480464 | CTD | |
| G | Gjb5 | gap junction protein, beta 5 |
|
affects expression | ISO | 5 | 146,802,849 | 146,803,664 | RGD:6480464 | CTD | |
| G | Glb1 | galactosidase, beta 1 |
|
affects expression | ISO | 8 | 118,791,550 | 118,864,281 | RGD:6480464 | CTD | |
| G | Glg1 | golgi glycoprotein 1 |
|
affects expression | ISO | 19 | 41,082,324 | 41,176,959 | RGD:6480464 | CTD | |
| G | Gli1 | GLI family zinc finger 1 |
|
affects expression | ISO | 7 | 67,288,291 | 67,297,461 | RGD:6480464 | CTD | |
| G | Glrb | glycine receptor, beta |
|
affects expression | ISO | 2 | 172,451,807 | 172,522,841 | RGD:6480464 | CTD | |
| G | Glrx3 | glutaredoxin 3 |
|
increases expression | ISO | 1 | 197,176,020 | 197,206,249 | RGD:6480464 | CTD | |
| G | Glrx3 | glutaredoxin 3 |
|
increases expression | EXP | 1 | 197,176,020 | 197,206,249 | RGD:6480464 | CTD | |
| G | Glrx5 | glutaredoxin 5 |
|
affects expression | ISO | 6 | 129,233,209 | 129,243,293 | RGD:6480464 | CTD | |
| G | Glud1 | glutamate dehydrogenase 1 |
|
decreases expression | ISO | 16 | 9,965,718 | 9,999,254 | RGD:6480464 | CTD | |
| G | Glud1 | glutamate dehydrogenase 1 |
|
multiple interactions | ISO | 16 | 9,965,718 | 9,999,254 | RGD:6480464 | CTD | |
| G | Glul | glutamate-ammonia ligase | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Glyat | glycine-N-acyltransferase |
|
affects expression | ISO | 1 | 215,653,254 | 215,666,991 | RGD:6480464 | CTD | |
| G | Glycam1 | glycosylation dependent cell adhesion molecule 1 |
|
affects expression | ISO | 7 | 142,455,642 | 142,457,902 | RGD:6480464 | CTD | |
| G | Gmip | Gem-interacting protein |
|
affects expression | ISO | 16 | 20,086,046 | 20,099,349 | RGD:6480464 | CTD | |
| G | Gnao1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
affects expression | ISO | 19 | 11,472,083 | 11,623,600 | RGD:6480464 | CTD | |
| G | Gnat1 | guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 |
|
affects expression | ISO | 8 | 112,925,418 | 112,930,154 | RGD:6480464 | CTD | |
| G | Gnb4 | guanine nucleotide binding protein (G protein), beta polypeptide 4 |
|
increases expression | ISO | 2 | 118,791,192 | 118,827,413 | RGD:6480464 | CTD | |
| G | Gzmbl2 | Granzyme B-like 2 |
|
decreases expression | ISO | 15 | 35,061,676 | 35,074,048 | RGD:6480464 | CTD | |
| G | Gzmbl2 | Granzyme B-like 2 |
|
increases expression | ISO | 15 | 35,061,676 | 35,074,048 | RGD:6480464 | CTD | |
| G | Hdac2 | histone deacetylase 2 |
|
affects expression | ISO | 20 | 41,162,093 | 41,186,492 | RGD:6480464 | CTD | |
| G | Hdac4 | histone deacetylase 4 |
|
multiple interactions | ISO | 9 | 91,147,435 | 91,389,810 | RGD:6480464 | CTD | |
| G | Hdac6 | histone deacetylase 6 |
|
affects expression | ISO | X | 26,585,852 | 26,606,999 | RGD:6480464 | CTD | |
| G | Hddc3 | HD domain containing 3 |
|
affects expression | ISO | 1 | 136,161,425 | 136,163,710 | RGD:6480464 | CTD | |
| G | Hdhd1 | haloacid dehalogenase-like hydrolase domain containing 1 |
|
affects expression | ISO | 18 | 45,741,982 | 45,743,005 | RGD:6480464 | CTD | |
| G | Hdhd3 | haloacid dehalogenase-like hydrolase domain containing 3 |
|
affects expression | ISO | 5 | 79,494,960 | 79,498,427 | RGD:6480464 | CTD | |
| G | Heg1 | heart development protein with EGF-like domains 1 |
|
affects expression | ISO | 11 11 |
68,828,748 68,828,748 |
68,889,177 68,912,073 |
RGD:6480464 | CTD | |
| G | Heg1 | heart development protein with EGF-like domains 1 |
|
multiple interactions | ISO | 11 11 |
68,828,748 68,828,748 |
68,889,177 68,912,073 |
RGD:6480464 | CTD | |
| G | Helb | helicase (DNA) B |
|
affects expression | ISO | 7 | 59,311,833 | 59,338,961 | RGD:6480464 | CTD | |
| G | Herpud1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
affects expression | ISO | 19 | 11,036,567 | 11,046,914 | RGD:6480464 | CTD | |
| G | Hexa | hexosaminidase A |
|
affects expression | ISO | 8 | 63,363,219 | 63,388,146 | RGD:6480464 | CTD | |
| G | Heyl | hairy/enhancer-of-split related with YRPW motif-like |
|
affects expression | ISO | 5 | 142,544,185 | 142,561,176 | RGD:6480464 | CTD | |
| G | Hgf | hepatocyte growth factor |
|
affects expression | ISO | 4 | 14,864,357 | 14,932,513 | RGD:6480464 | CTD | |
| G | Hic1 | hypermethylated in cancer 1 |
|
increases expression | ISO | 10 | 62,470,736 | 62,476,506 | RGD:6480464 | CTD | |
| G | Hic1 | hypermethylated in cancer 1 |
|
increases response to substance | ISO | 10 | 62,470,736 | 62,476,506 | RGD:6480464 | CTD | |
| G | Hic2 | hypermethylated in cancer 2 |
|
affects expression | ISO | 11 | 85,740,737 | 85,770,511 | RGD:6480464 | CTD | |
| G | Hif1a | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases response to substance | ISO | 6 | 96,419,024 | 96,463,891 | RGD:6480464 | CTD | |
| G | Hint1 | histidine triad nucleotide binding protein 1 |
|
affects expression | ISO | 10 | 40,271,895 | 40,275,640 | RGD:6480464 | CTD | |
| G | Hip1 | huntingtin interacting protein 1 |
|
increases expression | ISO | 12 | 22,287,861 | 22,422,163 | RGD:6480464 | CTD | |
| G | Hk1 | hexokinase 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Hmbs | hydroxymethylbilane synthase |
|
decreases expression | ISO | 8 | 47,314,235 | 47,321,604 | RGD:6480464 | CTD | |
| G | Hmg20a | high mobility group 20A |
|
affects expression | ISO | 8 | 60,014,815 | 60,091,988 | RGD:6480464 | CTD | |
| G | Hmgb2 | high mobility group box 2 |
|
affects expression | ISO | 16 | 36,131,304 | 36,133,878 | RGD:6480464 | CTD | |
| G | Hmgcr | 3-hydroxy-3-methylglutaryl-CoA reductase |
|
affects expression | ISO | 2 | 27,127,504 | 27,149,580 | RGD:6480464 | CTD | |
| G | Hmgcs1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
affects expression | ISO | 2 | 51,737,090 | 51,754,583 | RGD:6480464 | CTD | |
| G | Hmgcs2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
decreases expression | ISO | 2 | 193,128,736 | 193,143,106 | RGD:6480464 | CTD | |
| G | Hmgcs2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
affects expression | ISO | 2 | 193,128,736 | 193,143,106 | RGD:6480464 | CTD | |
| G | Hmgn1 | high mobility group nucleosome binding domain 1 |
|
affects expression | ISO | 11 | 36,429,800 | 36,435,719 | RGD:6480464 | CTD | |
| G | Hmha1 | histocompatibility (minor) HA-1 |
|
affects expression | ISO | 7 | 11,187,348 | 11,202,717 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
affects expression | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
decreases expression | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hn1 | hematological and neurological expressed 1 |
|
affects expression | ISO | 10 | 105,579,880 | 105,598,071 | RGD:6480464 | CTD | |
| G | Hnf4a | hepatocyte nuclear factor 4, alpha |
|
affects expression | ISO | 3 | 154,459,863 | 154,482,825 | RGD:6480464 | CTD | |
| G | Hnf4a | hepatocyte nuclear factor 4, alpha |
|
decreases activity | ISO | 3 | 154,459,863 | 154,482,825 | RGD:6480464 | CTD | |
| G | Hnrnpa3 | heterogeneous nuclear ribonucleoprotein A3 |
|
affects expression | ISO | 3 | 68,872,863 | 68,875,337 | RGD:6480464 | CTD | |
| G | Hnrnpab | heterogeneous nuclear ribonucleoprotein A/B |
|
decreases expression | ISO | 10 | 37,117,285 | 37,123,177 | RGD:6480464 | CTD | |
| G | Hnrnpab | heterogeneous nuclear ribonucleoprotein A/B |
|
multiple interactions | ISO | 10 | 37,117,285 | 37,123,177 | RGD:6480464 | CTD | |
| G | Hnrnpab | heterogeneous nuclear ribonucleoprotein A/B |
|
affects expression | ISO | 10 | 37,117,285 | 37,123,177 | RGD:6480464 | CTD | |
| G | Hnrnpab | heterogeneous nuclear ribonucleoprotein A/B |
|
increases expression | ISO | 10 | 37,117,285 | 37,123,177 | RGD:6480464 | CTD | |
| G | Hnrnpab | heterogeneous nuclear ribonucleoprotein A/B |
|
increases expression | EXP | 10 | 37,117,285 | 37,123,177 | RGD:6480464 | CTD | |
| G | Hnrnph2 | heterogeneous nuclear ribonucleoprotein H2 (H') |
|
increases expression | ISO | X | 122,056,647 | 122,061,844 | RGD:6480464 | CTD | |
| G | Hnrnph2 | heterogeneous nuclear ribonucleoprotein H2 (H') |
|
multiple interactions | ISO | X | 122,056,647 | 122,061,844 | RGD:6480464 | CTD | |
| G | Hnrnph3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) |
|
decreases expression | ISO | 20 | 25,353,281 | 25,358,138 | RGD:6480464 | CTD | |
| G | Hnrnph3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) |
|
multiple interactions | ISO | 20 | 25,353,281 | 25,358,138 | RGD:6480464 | CTD | |
| G | Hnrnpu | heterogeneous nuclear ribonucleoprotein U |
|
affects expression | ISO | 13 | 93,978,865 | 93,987,654 | RGD:6480464 | CTD | |
| G | Hnrnpu | heterogeneous nuclear ribonucleoprotein U |
|
affects expression | ISO | 13 | 93,978,865 | 93,987,654 | RGD:6480464 | CTD | |
| G | Hnrnpu | heterogeneous nuclear ribonucleoprotein U |
|
increases expression | ISO | 13 | 93,978,865 | 93,987,654 | RGD:6480464 | CTD | |
| G | Hnrnpu | heterogeneous nuclear ribonucleoprotein U |
|
increases expression | EXP | 13 | 93,978,865 | 93,987,654 | RGD:6480464 | CTD | |
| G | Homer2 | homer homolog 2 (Drosophila) |
|
affects expression | ISO | 1 | 137,827,128 | 137,933,089 | RGD:6480464 | CTD | |
| G | Homer2 | homer homolog 2 (Drosophila) |
|
decreases expression | ISO | 1 | 137,827,128 | 137,933,089 | RGD:6480464 | CTD | |
| G | Hpcal1 | hippocalcin-like 1 |
|
multiple interactions | ISO | 6 | 41,458,062 | 41,576,771 | RGD:6480464 | CTD | |
| G | Hpn | hepsin |
|
increases expression | ISO | 1 | 86,145,615 | 86,161,091 | RGD:6480464 | CTD | |
| G | Hprt1 | hypoxanthine phosphoribosyltransferase 1 |
|
affects expression | ISO | X | 139,929,647 | 139,961,616 | RGD:6480464 | CTD | |
| G | Hpx | hemopexin |
|
affects expression | ISO | 1 | 163,319,509 | 163,327,017 | RGD:6480464 | CTD | |
| G | Hrg | histidine-rich glycoprotein |
|
decreases response to substance | ISO | 11 | 80,248,578 | 80,264,179 | RGD:6480464 | CTD | |
| G | Hrk | harakiri, BCL2 interacting protein (contains only BH3 domain) |
|
affects expression | ISO | 12 | 39,520,265 | 39,543,901 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
affects expression | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspe1 | heat shock protein 1 (chaperonin 10) |
|
affects expression | ISO | 9 | 53,895,333 | 53,898,421 | RGD:6480464 | CTD | |
| G | Hspe1 | heat shock protein 1 (chaperonin 10) |
|
increases expression | ISO | 9 | 53,895,333 | 53,898,421 | RGD:6480464 | CTD | |
| G | Hyi | hydroxypyruvate isomerase |
|
affects expression | ISO | 5 | 138,842,872 | 138,843,826 | RGD:6480464 | CTD | |
| G | Ifitm1 | interferon induced transmembrane protein 1 |
|
increases expression | ISO | 1 | 201,154,494 | 201,155,509 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
increases expression | EXP | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
multiple interactions | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1r | insulin-like growth factor 1 receptor |
|
increases expression | ISO | 1 | 122,704,976 | 122,990,007 | RGD:6480464 | CTD | |
| G | Igf2 | insulin-like growth factor 2 |
|
multiple interactions | ISO | 1 | 202,906,624 | 202,915,231 | RGD:6480464 | CTD | |
| G | Igf2 | insulin-like growth factor 2 |
|
decreases secretion | ISO | 1 | 202,906,624 | 202,915,231 | RGD:6480464 | CTD | |
| G | Igf2 | insulin-like growth factor 2 |
|
affects expression | ISO | 1 | 202,906,624 | 202,915,231 | RGD:6480464 | CTD | |
| G | Igfbp1 | insulin-like growth factor binding protein 1 |
|
multiple interactions | ISO | 14 | 87,950,222 | 87,955,289 | RGD:6480464 | CTD | |
| G | Igfbp1 | insulin-like growth factor binding protein 1 |
|
affects expression | ISO | 14 | 87,950,222 | 87,955,289 | RGD:6480464 | CTD | |
| G | Igfbp2 | insulin-like growth factor binding protein 2 |
|
increases expression | ISO | 9 | 71,966,877 | 71,994,211 | RGD:6480464 | CTD | |
| G | Igfbp3 | insulin-like growth factor binding protein 3 |
|
multiple interactions | ISO | 14 | 87,959,153 | 87,967,085 | RGD:6480464 | CTD | |
| G | Igfbp4 | insulin-like growth factor binding protein 4 |
|
affects expression | ISO | 10 | 87,822,429 | 87,834,315 | RGD:6480464 | CTD | |
| G | Igfbp4 | insulin-like growth factor binding protein 4 |
|
affects expression | ISO | 10 | 87,822,429 | 87,834,315 | RGD:6480464 | CTD | |
| G | Igfbp5 | insulin-like growth factor binding protein 5 |
|
affects expression | ISO | 9 | 72,003,637 | 72,016,263 | RGD:6480464 | CTD | |
| G | Igfbp5 | insulin-like growth factor binding protein 5 |
|
increases response to substance | ISO | 9 | 72,003,637 | 72,016,263 | RGD:6480464 | CTD | |
| G | Igfbp6 | insulin-like growth factor binding protein 6 |
|
affects expression | ISO | 7 | 140,885,388 | 140,890,028 | RGD:6480464 | CTD | |
| G | Igtp | interferon gamma induced GTPase |
|
affects expression | ISO | 10 | 43,829,273 | 43,837,092 | RGD:6480464 | CTD | |
| G | Il17ra | interleukin 17 receptor A |
|
affects expression | ISO | 4 | 156,838,353 | 156,862,345 | RGD:6480464 | CTD | |
| G | Il1b | interleukin 1 beta |
|
decreases expression | ISO | 3 | 116,964,422 | 116,970,867 | RGD:6480464 | CTD | |
| G | Il1b | interleukin 1 beta |
|
decreases expression | ISO | 3 | 116,964,422 | 116,970,867 | RGD:6480464 | CTD | |
| G | Il1b | interleukin 1 beta |
|
multiple interactions | ISO | 3 | 116,964,422 | 116,970,867 | RGD:6480464 | CTD | |
| G | Il1b | interleukin 1 beta |
|
multiple interactions | ISO | 3 | 116,964,422 | 116,970,867 | RGD:6480464 | CTD | |
| G | Il1b | interleukin 1 beta |
|
decreases expression | EXP | 3 | 116,964,422 | 116,970,867 | RGD:6480464 | CTD | |
| G | Il1r1 | interleukin 1 receptor, type I |
|
affects expression | ISO | 9 | 39,434,910 | 39,473,552 | RGD:6480464 | CTD | |
| G | Il24 | interleukin 24 |
|
decreases expression | ISO | 13 | 43,831,510 | 43,836,908 | RGD:6480464 | CTD | |
| G | Il2rg | interleukin 2 receptor, gamma |
|
affects expression | ISO | X | 89,342,055 | 89,345,715 | RGD:6480464 | CTD | |
| G | Il4 | interleukin 4 |
|
decreases expression | ISO | 10 | 39,074,582 | 39,080,134 | RGD:6480464 | CTD | |
| G | Il4 | interleukin 4 |
|
affects expression | ISO | 10 | 39,074,582 | 39,080,134 | RGD:6480464 | CTD | |
| G | Il4 | interleukin 4 |
|
increases expression | ISO | 10 | 39,074,582 | 39,080,134 | RGD:6480464 | CTD | |
| G | Il4r | interleukin 4 receptor |
|
affects expression | ISO | 1 | 184,612,903 | 184,637,863 | RGD:6480464 | CTD | |
| G | Il4r | interleukin 4 receptor |
|
increases expression | ISO | 1 | 184,612,903 | 184,637,863 | RGD:6480464 | CTD | |
| G | Il5 | interleukin 5 |
|
affects expression | ISO | 10 | 39,177,786 | 39,180,657 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
decreases expression | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
decreases expression | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
decreases activity | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
increases expression | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | EXP | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il7 | interleukin 7 |
|
decreases expression | ISO | 2 | 96,356,083 | 96,399,796 | RGD:6480464 | CTD | |
| G | Ilk | integrin-linked kinase |
|
affects expression | ISO | 1 | 163,481,299 | 163,487,550 | RGD:6480464 | CTD | |
| G | Ing1 | inhibitor of growth family, member 1 |
|
affects expression | ISO | 16 | 82,789,254 | 82,790,319 | RGD:6480464 | CTD | |
| G | Ing4 | inhibitor of growth family, member 4 |
|
affects expression | ISO | 4 | 161,161,044 | 161,169,603 | RGD:6480464 | CTD | |
| G | Inhba | inhibin beta-A |
|
affects expression | ISO | 17 | 57,244,466 | 57,257,531 | RGD:6480464 | CTD | |
| G | Inhba | inhibin beta-A |
|
multiple interactions | ISO | 17 | 57,244,466 | 57,257,531 | RGD:6480464 | CTD | |
| G | Inhbb | inhibin beta-B |
|
affects expression | ISO | 13 | 32,170,987 | 32,176,689 | RGD:6480464 | CTD | |
| G | Inhbb | inhibin beta-B |
|
increases expression | ISO | 13 | 32,170,987 | 32,176,689 | RGD:6480464 | CTD | |
| G | Inhbe | inhibin beta E |
|
increases expression | ISO | 7 | 67,308,713 | 67,310,138 | RGD:6480464 | CTD | |
| G | Inhbe | inhibin beta E |
|
affects expression | ISO | 7 | 67,308,713 | 67,310,138 | RGD:6480464 | CTD | |
| G | Inpp5a | inositol polyphosphate-5-phosphatase A |
|
multiple interactions | ISO | 1 | 199,187,936 | 199,395,997 | RGD:6480464 | CTD | |
| G | Inpp5a | inositol polyphosphate-5-phosphatase A |
|
affects expression | ISO | 1 | 199,187,936 | 199,395,997 | RGD:6480464 | CTD | |
| G | Insig2 | insulin induced gene 2 |
|
affects expression | ISO | 13 | 33,331,951 | 33,345,132 | RGD:6480464 | CTD | |
| G | Insl3 | insulin-like 3 |
|
affects expression | ISO | 16 | 18,890,131 | 18,891,475 | RGD:6480464 | CTD | |
| G | Insl6 | insulin-like 6 |
|
affects expression | ISO | 1 | 232,990,534 | 232,994,069 | RGD:6480464 | CTD | |
| G | Ints6 | integrator complex subunit 6 |
|
affects expression | ISO | 15 | 41,984,682 | 42,030,867 | RGD:6480464 | CTD | |
| G | Irgm2 | immunity-related GTPase family M member 2 |
|
affects expression | ISO | 10 | 43,844,486 | 43,854,570 | RGD:6480464 | CTD | |
| G | Kdm5a | lysine (K)-specific demethylase 5A |
|
increases expression | ISO | 4 | 156,736,343 | 156,811,991 | RGD:6480464 | CTD | |
| G | Kif3c | kinesin family member 3C |
|
multiple interactions | ISO | 6 | 26,342,388 | 26,381,233 | RGD:6480464 | CTD | |
| G | Kif4a | kinesin family member 4A |
|
affects expression | ISO | X | 88,624,683 | 88,742,447 | RGD:6480464 | CTD | |
| G | Kif5b | kinesin family member 5B |
|
affects expression | ISO | 17 | 59,697,082 | 59,727,314 | RGD:6480464 | CTD | |
| G | Klf10 | Kruppel-like factor 10 |
|
affects expression | ISO | 7 | 73,821,190 | 73,826,866 | RGD:6480464 | CTD | |
| G | Klf7 | Kruppel-like factor 7 (ubiquitous) |
|
affects expression | ISO | 9 | 62,690,536 | 62,738,089 | RGD:6480464 | CTD | |
| G | Klf9 | Kruppel-like factor 9 |
|
affects expression | ISO | 1 | 226,420,949 | 226,446,376 | RGD:6480464 | CTD | |
| G | Klhdc2 | kelch domain containing 2 |
|
affects expression | ISO | 6 | 91,259,826 | 91,274,820 | RGD:6480464 | CTD | |
| G | Klhl10 | kelch-like family member 10 |
|
affects expression | ISO | 10 | 89,385,247 | 89,401,614 | RGD:6480464 | CTD | |
| G | Klk8 | kallikrein related-peptidase 8 |
|
affects expression | ISO | 1 | 94,227,185 | 94,234,028 | RGD:6480464 | CTD | |
| G | Klk9 | kallikrein related-peptidase 9 |
|
affects expression | ISO | 1 | 94,221,721 | 94,226,013 | RGD:6480464 | CTD | |
| G | Klkb1 | kallikrein B, plasma 1 |
|
affects expression | ISO | 16 | 50,248,935 | 50,272,279 | RGD:6480464 | CTD | |
| G | Klkb1 | kallikrein B, plasma 1 |
|
affects expression | ISO | 16 | 50,248,935 | 50,272,279 | RGD:6480464 | CTD | |
| G | Klrc1 | killer cell lectin-like receptor subfamily C, member 1 |
|
increases expression | ISO | 4 | 166,976,056 | 166,986,568 | RGD:6480464 | CTD | |
| G | Klrc2 | killer cell lectin-like receptor subfamily C, member 2 |
|
multiple interactions | ISO | 4 | 166,956,614 | 166,967,757 | RGD:6480464 | CTD | |
| G | Klrk1 | killer cell lectin-like receptor subfamily K, member 1 |
|
multiple interactions | ISO | 4 | 166,914,786 | 166,922,659 | RGD:6480464 | CTD | |
| G | Krt1 | keratin 1 |
|
affects expression | ISO | 7 | 140,540,960 | 140,546,186 | RGD:6480464 | CTD | |
| G | Krt13 | keratin 13 |
|
increases expression | EXP | 10 | 89,057,240 | 89,061,150 | RGD:6480464 | CTD | |
| G | Krt13 | keratin 13 |
|
increases expression | ISO | 10 | 89,057,240 | 89,061,150 | RGD:6480464 | CTD | |
| G | Krt17 | keratin 17 |
|
multiple interactions | ISO | 10 | 89,185,097 | 89,189,816 | RGD:6480464 | CTD | |
| G | Krt17 | keratin 17 |
|
affects expression | ISO | 10 | 89,185,097 | 89,189,816 | RGD:6480464 | CTD | |
| G | Krt19 | keratin 19 |
|
affects expression | ISO | 10 | 89,080,953 | 89,085,670 | RGD:6480464 | CTD | |
| G | Krt34 | keratin 34 |
|
multiple interactions | ISO | 10 | 88,973,452 | 88,977,141 | RGD:6480464 | CTD | |
| G | Krt5 | keratin 5 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Krt7 | keratin 7 |
|
affects expression | ISO | 7 | 140,160,829 | 140,226,474 | RGD:6480464 | CTD | |
| G | Krt8 | keratin 8 |
|
increases expression | ISO | 7 | 140,713,902 | 140,721,199 | RGD:6480464 | CTD | |
| G | Krt8 | keratin 8 |
|
increases expression | EXP | 7 | 140,713,902 | 140,721,199 | RGD:6480464 | CTD | |
| G | Krt86 | keratin 86 |
|
decreases expression | ISO | 7 | 140,222,555 | 140,228,828 | RGD:6480464 | CTD | |
| G | Krtcap3 | keratinocyte associated protein 3 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Kynu | kynureninase |
|
increases expression | ISO | 3 | 24,046,242 | 24,195,898 | RGD:6480464 | CTD | |
| G | L3mbtl1 | l(3)mbt-like 1 (Drosophila) |
|
decreases expression | ISO | 3 | 153,811,334 | 153,836,990 | RGD:6480464 | CTD | |
| G | Lama3 | laminin, alpha 3 |
|
affects expression | ISO | 18 | 4,030,463 | 4,121,355 | RGD:6480464 | CTD | |
| G | Lama5 | laminin, alpha 5 |
|
affects expression | ISO | 3 | 169,233,897 | 169,282,410 | RGD:6480464 | CTD | |
| G | Lamc1 | laminin, gamma 1 |
|
affects expression | ISO | 13 | 68,241,453 | 68,369,419 | RGD:6480464 | CTD | |
| G | Lamc2 | laminin, gamma 2 |
|
affects expression | ISO | 13 | 68,151,074 | 68,211,117 | RGD:6480464 | CTD | |
| G | Lamp2 | lysosomal-associated membrane protein 2 |
|
affects expression | ISO | X | 6,908,285 | 6,951,772 | RGD:6480464 | CTD | |
| G | Lancl1 | LanC lantibiotic synthetase component C-like 1 (bacterial) |
|
affects expression | ISO | 9 | 65,799,079 | 65,828,986 | RGD:6480464 | CTD | |
| G | Larp6 | La ribonucleoprotein domain family, member 6 |
|
increases expression | ISO | 8 | 64,655,008 | 64,676,258 | RGD:6480464 | CTD | |
| G | Larp7 | La ribonucleoprotein domain family, member 7 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Lbh | limb bud and heart development |
|
multiple interactions | ISO | 6 | 22,662,376 | 22,664,667 | RGD:6480464 | CTD | |
| G | Lck | lymphocyte-specific protein tyrosine kinase |
|
affects expression | ISO | 5 | 148,707,505 | 148,718,296 | RGD:6480464 | CTD | |
| G | Lcn2 | lipocalin 2 |
|
affects expression | ISO | 3 | 11,511,402 | 11,514,747 | RGD:6480464 | CTD | |
| G | Lcn2 | lipocalin 2 |
|
affects expression | ISO | 3 | 11,511,402 | 11,514,747 | RGD:6480464 | CTD | |
| G | Lcp2 | lymphocyte cytosolic protein 2 |
|
affects expression | ISO | 10 | 19,019,978 | 19,066,744 | RGD:6480464 | CTD | |
| G | Ldb1 | LIM domain binding 1 |
|
decreases expression | ISO | 1 | 251,253,305 | 251,260,850 | RGD:6480464 | CTD | |
| G | Ldb2 | LIM domain binding 2 |
|
affects expression | ISO | 14 | 71,374,621 | 71,695,965 | RGD:6480464 | CTD | |
| G | Ldha | lactate dehydrogenase A |
|
increases expression | ISO | 1 | 97,403,077 | 97,412,547 | RGD:6480464 | CTD | |
| G | Ldha | lactate dehydrogenase A |
|
increases expression | EXP | 1 | 97,403,077 | 97,412,547 | RGD:6480464 | CTD | |
| G | Ldha | lactate dehydrogenase A |
|
affects expression | ISO | 1 | 97,403,077 | 97,412,547 | RGD:6480464 | CTD | |
| G | Ldhb | lactate dehydrogenase B |
|
affects expression | ISO | 4 | 180,061,567 | 180,079,473 | RGD:6480464 | CTD | |
| G | Ldhc | lactate dehydrogenase C |
|
affects expression | ISO | 1 | 97,418,622 | 97,435,275 | RGD:6480464 | CTD | |
| G | Lef1 | lymphoid enhancer binding factor 1 |
|
increases expression | ISO | 2 | 228,550,263 | 228,673,131 | RGD:6480464 | CTD | |
| G | Letm1 | leucine zipper-EF-hand containing transmembrane protein 1 |
|
affects expression | ISO | 14 | 82,637,839 | 82,677,419 | RGD:6480464 | CTD | |
| G | Lgals1 | lectin, galactoside-binding, soluble, 1 |
|
affects expression | ISO | 7 | 116,893,662 | 116,896,768 | RGD:6480464 | CTD | |
| G | Lgals3 | lectin, galactoside-binding, soluble, 3 |
|
affects expression | ISO | 15 | 23,327,071 | 23,339,006 | RGD:6480464 | CTD | |
| G | Lgals3bp | lectin, galactoside-binding, soluble, 3 binding protein |
|
increases expression | ISO | 10 | 108,388,185 | 108,397,523 | RGD:6480464 | CTD | |
| G | Lgals3bp | lectin, galactoside-binding, soluble, 3 binding protein |
|
affects expression | ISO | 10 | 108,388,185 | 108,397,523 | RGD:6480464 | CTD | |
| G | Lgals8 | lectin, galactoside-binding, soluble, 8 |
|
decreases expression | ISO | 17 | 68,589,595 | 68,614,014 | RGD:6480464 | CTD | |
| G | Lgr5 | leucine rich repeat containing G protein coupled receptor 5 |
|
multiple interactions | ISO | 7 | 54,737,745 | 54,876,664 | RGD:6480464 | CTD | |
| G | Lgr5 | leucine rich repeat containing G protein coupled receptor 5 |
|
affects expression | ISO | 7 | 54,737,745 | 54,876,664 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
affects secretion | ISO | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | LOC100360205 | palladin |
|
affects expression | ISO | 16 | 31,854,459 | 31,933,792 | RGD:6480464 | CTD | |
| G | LOC100360205 | palladin |
|
increases expression | ISO | 16 | 31,854,459 | 31,933,792 | RGD:6480464 | CTD | |
| G | LOC100360260 | chromobox homolog 3-like |
|
decreases expression | ISO | 16 | 32,507,709 | 32,508,260 | RGD:6480464 | CTD | |
| G | LOC100360920 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
affects expression | ISO | 12 | 11,498,420 | 11,513,595 | RGD:6480464 | CTD | |
| G | LOC100363014 | REST corepressor 1-like |
|
affects expression | ISO | 6 | 135,779,610 | 135,858,591 | RGD:6480464 | CTD | |
| G | LOC501282 | similar to lymphocyte antigen 6 complex, locus E ligand | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Lrrfip1 | leucine rich repeat (in FLII) interacting protein 1 |
|
affects expression | ISO | 9 | 90,278,891 | 90,346,980 | RGD:6480464 | CTD | |
| G | Lyrm5 | LYR motif containing 5 |
|
affects expression | ISO | 4 | 182,859,926 | 182,865,036 | RGD:6480464 | CTD | |
| G | Macf1 | microtubule-actin crosslinking factor 1 |
|
affects expression | ISO | 5 | 142,659,726 | 142,986,873 | RGD:6480464 | CTD | |
| G | Map3k5 | mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions | ISO | 1 | 15,205,361 | 15,346,422 | RGD:6480464 | CTD | |
| G | Map3k8 | mitogen-activated protein kinase kinase kinase 8 |
|
multiple interactions | ISO | 17 | 61,910,179 | 61,930,459 | RGD:6480464 | CTD | |
| G | Map4 | microtubule-associated protein 4 |
|
affects expression | ISO | 8 | 114,300,908 | 114,438,008 | RGD:6480464 | CTD | |
| G | Map7 | microtubule-associated protein 7 |
|
affects expression | ISO | 1 | 15,440,422 | 15,553,260 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
increases phosphorylation | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
decreases phosphorylation | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | EXP | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk10 | mitogen activated protein kinase 10 |
|
affects expression | ISO | 14 | 7,719,595 | 8,010,694 | RGD:6480464 | CTD | |
| G | Mapk11 | mitogen-activated protein kinase 11 |
|
decreases expression | ISO | 7 | 127,444,055 | 127,449,990 | RGD:6480464 | CTD | |
| G | Mapk14 | mitogen activated protein kinase 14 |
|
increases activity | ISO | 20 | 6,939,249 | 7,000,378 | RGD:6480464 | CTD | |
| G | Mapk14 | mitogen activated protein kinase 14 |
|
multiple interactions | ISO | 20 | 6,939,249 | 7,000,378 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
decreases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases activity | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | EXP | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk7 | mitogen-activated protein kinase 7 |
|
affects expression | ISO | 10 | 47,649,203 | 47,654,316 | RGD:6480464 | CTD | |
| G | Mapk8 | mitogen-activated protein kinase 8 |
|
multiple interactions | ISO | 16 | 8,925,133 | 9,004,897 | RGD:6480464 | CTD | |
| G | Mapk8 | mitogen-activated protein kinase 8 |
|
increases activity | ISO | 16 | 8,925,133 | 9,004,897 | RGD:6480464 | CTD | |
| G | Mapk9 | mitogen-activated protein kinase 9 |
|
affects expression | ISO | 10 | 35,353,486 | 35,384,319 | RGD:6480464 | CTD | |
| G | Mapkapk2 | mitogen-activated protein kinase-activated protein kinase 2 |
|
multiple interactions | ISO | 13 | 43,994,943 | 44,041,504 | RGD:6480464 | CTD | |
| G | Mapt | microtubule-associated protein tau |
|
multiple interactions | ISO | 10 | 93,411,098 | 93,508,762 | RGD:6480464 | CTD | |
| G | Mapt | microtubule-associated protein tau |
|
increases expression | ISO | 10 | 93,411,098 | 93,508,762 | RGD:6480464 | CTD | |
| G | Mapt | microtubule-associated protein tau |
|
affects expression | ISO | 10 | 93,411,098 | 93,508,762 | RGD:6480464 | CTD | |
| G | Marcks | myristoylated alanine rich protein kinase C substrate |
|
affects expression | ISO | 20 | 41,304,058 | 41,310,104 | RGD:6480464 | CTD | |
| G | Marcksl1 | MARCKS-like 1 |
|
affects expression | ISO | 5 | 148,669,499 | 148,672,337 | RGD:6480464 | CTD | |
| G | Mass1 | monogenic, audiogenic seizure susceptibility 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Mat1a | methionine adenosyltransferase I, alpha |
|
decreases expression | ISO | 16 | 17,548,582 | 17,563,989 | RGD:6480464 | CTD | |
| G | Matn2 | matrilin 2 |
|
affects expression | ISO | 7 | 69,715,611 | 69,880,723 | RGD:6480464 | CTD | |
| G | Matr3 | matrin 3 |
|
affects expression | ISO | 18 | 28,171,639 | 28,215,659 | RGD:6480464 | CTD | |
| G | Mb | myoglobin |
|
affects expression | ISO | 7 | 115,087,558 | 115,094,789 | RGD:6480464 | CTD | |
| G | Mbd1 | methyl-CpG binding domain protein 1 |
|
affects expression | ISO | 18 | 71,068,257 | 71,082,734 | RGD:6480464 | CTD | |
| G | Mbnl1 | muscleblind-like splicing regulator 1 |
|
affects expression | ISO | 2 | 149,891,873 | 150,004,089 | RGD:6480464 | CTD | |
| G | Mbnl2 | muscleblind-like splicing regulator 2 |
|
multiple interactions | ISO | 15 | 105,356,456 | 105,514,135 | RGD:6480464 | CTD | |
| G | Mboat2 | membrane bound O-acyltransferase domain containing 2 |
|
affects expression | ISO | 6 | 42,486,112 | 42,608,004 | RGD:6480464 | CTD | |
| G | Mbp | myelin basic protein |
|
multiple interactions | ISO | 18 | 78,943,608 | 79,057,329 | RGD:6480464 | CTD | |
| G | Mbp | myelin basic protein |
|
increases expression | ISO | 18 | 78,943,608 | 79,057,329 | RGD:6480464 | CTD | |
| G | Mc2r | melanocortin 2 receptor (adrenocorticotropic hormone) |
|
decreases expression | ISO | 18 | 64,591,344 | 64,601,883 | RGD:6480464 | CTD | |
| G | Mcfd2 | multiple coagulation factor deficiency 2 |
|
affects expression | ISO | 6 | 10,763,516 | 10,774,854 | RGD:6480464 | CTD | |
| G | Mcl1 | myeloid cell leukemia sequence 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Mcm2 | minichromosome maintenance complex component 2 |
|
affects expression | ISO | 4 | 122,977,522 | 122,991,934 | RGD:6480464 | CTD | |
| G | Mcm6 | minichromosome maintenance complex component 6 |
|
increases expression | ISO | 13 | 41,045,677 | 41,070,868 | RGD:6480464 | CTD | |
| G | Mcm6 | minichromosome maintenance complex component 6 |
|
multiple interactions | ISO | 13 | 41,045,677 | 41,070,868 | RGD:6480464 | CTD | |
| G | Mcm6 | minichromosome maintenance complex component 6 |
|
affects expression | ISO | 13 | 41,045,677 | 41,070,868 | RGD:6480464 | CTD | |
| G | Mcm7 | minichromosome maintenance complex component 7 |
|
decreases expression | ISO | 12 | 17,607,250 | 17,614,508 | RGD:6480464 | CTD | |
| G | Mdfic | MyoD family inhibitor domain containing |
|
affects expression | ISO | 4 | 41,241,856 | 41,321,515 | RGD:6480464 | CTD | |
| G | Mdfic | MyoD family inhibitor domain containing |
|
multiple interactions | ISO | 4 | 41,241,856 | 41,321,515 | RGD:6480464 | CTD | |
| G | Mdh2 | malate dehydrogenase 2, NAD (mitochondrial) |
|
affects expression | ISO | 12 | 22,021,302 | 22,034,257 | RGD:6480464 | CTD | |
| G | Mdk | midkine |
|
affects expression | ISO | 3 | 76,309,988 | 76,311,345 | RGD:6480464 | CTD | |
| G | Mdm2 | p53 E3 ubiquitin protein ligase |
|
affects expression | ISO | 7 | 56,996,694 | 57,020,926 | RGD:6480464 | CTD | |
| G | Mdn1 | midasin homolog (yeast) |
|
affects expression | ISO | 5 | 48,961,431 | 49,082,520 | RGD:6480464 | CTD | |
| G | Mpa2l | macrophage activation 2 like |
|
affects expression | ISO | 14 | 5,846,667 | 5,863,299 | RGD:6480464 | CTD | |
| G | Mrpl13 | mitochondrial ribosomal protein L13 |
|
affects expression | ISO | 7 | 92,047,293 | 92,068,851 | RGD:6480464 | CTD | |
| G | Mrpl17 | mitochondrial ribosomal protein L17 |
|
affects expression | ISO | 1 | 163,554,720 | 163,556,294 | RGD:6480464 | CTD | |
| G | Mrpl2 | mitochondrial ribosomal protein L2 |
|
affects expression | ISO | 9 | 10,016,260 | 10,020,033 | RGD:6480464 | CTD | |
| G | mrpl24 | mitochondrial ribosomal protein L24 |
|
affects expression | ISO | 2 | 179,995,713 | 180,001,745 | RGD:6480464 | CTD | |
| G | Mrpl3 | mitochondrial ribosomal protein L3 |
|
affects expression | ISO | 8 | 110,130,050 | 110,153,411 | RGD:6480464 | CTD | |
| G | Mrpl33 | mitochondrial ribosomal protein L33 |
|
affects expression | ISO | 6 | 24,870,269 | 24,878,462 | RGD:6480464 | CTD | |
| G | Mrpl37 | mitochondrial ribosomal protein L37 |
|
affects expression | ISO | 5 | 128,135,417 | 128,145,916 | RGD:6480464 | CTD | |
| G | Mrpl51 | mitochondrial ribosomal protein L51 |
|
affects expression | ISO | 4 | 161,311,611 | 161,314,569 | RGD:6480464 | CTD | |
| G | Mrps18b | mitochondrial ribosomal protein S18B |
|
affects expression | ISO | 20 | 2,985,972 | 2,992,031 | RGD:6480464 | CTD | |
| G | Mrps23 | mitochondrial ribosomal protein S23 |
|
affects expression | ISO | 10 | 76,500,621 | 76,508,379 | RGD:6480464 | CTD | |
| G | Mrps25 | mitochondrial ribosomal protein S25 |
|
affects expression | ISO | 4 | 126,351,113 | 126,362,876 | RGD:6480464 | CTD | |
| G | Mrps31 | mitochondrial ribosomal protein S31 |
|
affects expression | ISO | 16 | 74,249,818 | 74,270,032 | RGD:6480464 | CTD | |
| G | Msmb | microseminoprotein, beta |
|
multiple interactions | ISO | 16 | 7,619,432 | 7,640,019 | RGD:6480464 | CTD | |
| G | Msmo1 | methylsterol monooxygenase 1 |
|
affects expression | ISO | 16 | 26,698,324 | 26,716,247 | RGD:6480464 | CTD | |
| G | Mst1 | Macrophage stimulating 1 (hepatocyte growth factor-like) |
|
increases expression | ISO | 8 | 113,348,203 | 113,352,773 | RGD:6480464 | CTD | |
| G | Mt1a | metallothionein 1a |
|
affects expression | ISO | 19 | 11,261,631 | 11,262,647 | RGD:6480464 | CTD | |
| G | Mt1a | metallothionein 1a |
|
multiple interactions | ISO | 19 | 11,261,631 | 11,262,647 | RGD:6480464 | CTD | |
| G | Mt2A | metallothionein 2A |
|
affects expression | ISO | 19 | 11,267,811 | 11,268,585 | RGD:6480464 | CTD | |
| G | Mterfd2 | MTERF domain containing 2 |
|
affects expression | ISO | 9 | 92,572,064 | 92,576,740 | RGD:6480464 | CTD | |
| G | Mthfd1l | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
|
affects expression | ISO | 1 | 34,759,445 | 34,800,865 | RGD:6480464 | CTD | |
| G | Mthfd2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
|
affects expression | ISO | 4 | 117,517,611 | 117,529,128 | RGD:6480464 | CTD | |
| G | Mthfr | methylenetetrahydrofolate reductase (NAD(P)H) |
|
decreases expression | ISO | 5 | 165,112,850 | 165,126,885 | RGD:6480464 | CTD | |
| G | Mtmr2 | myotubularin related protein 2 |
|
increases expression | ISO | 8 | 10,556,644 | 10,606,844 | RGD:6480464 | CTD | |
| G | Mtor | mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases activity | ISO | 5 | 165,531,402 | 165,640,899 | RGD:6480464 | CTD | |
| G | Mtor | mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions | ISO | 5 | 165,531,402 | 165,640,899 | RGD:6480464 | CTD | |
| G | Mtor | mechanistic target of rapamycin (serine/threonine kinase) |
|
affects expression | ISO | 5 | 165,531,402 | 165,640,899 | RGD:6480464 | CTD | |
| G | Mtss1 | metastasis suppressor 1 |
|
affects expression | ISO | 7 | 95,808,266 | 95,947,927 | RGD:6480464 | CTD | |
| G | Mtx1 | Metaxin 1 |
|
affects expression | ISO | 2 | 181,379,690 | 181,381,406 | RGD:6480464 | CTD | |
| G | Muc1 | mucin 1, cell surface associated |
|
affects response to substance | ISO | 2 | 181,399,482 | 181,403,640 | RGD:6480464 | CTD | |
| G | Mustn1 | musculoskeletal, embryonic nuclear protein 1 |
|
affects expression | ISO | 16 | 6,311,978 | 6,314,228 | RGD:6480464 | CTD | |
| G | Mutyh | mutY homolog (E. coli) |
|
affects expression | ISO | 5 | 137,103,958 | 137,115,897 | RGD:6480464 | CTD | |
| G | Mvd | mevalonate (diphospho) decarboxylase |
|
affects expression | ISO | 19 | 52,722,306 | 52,732,312 | RGD:6480464 | CTD | |
| G | Mxi1 | MAX interactor 1, dimerization protein |
|
affects expression | ISO | 1 | 259,219,584 | 259,259,979 | RGD:6480464 | CTD | |
| G | Mybl2 | myeloblastosis oncogene-like 2 |
|
affects expression | ISO | 3 | 153,925,908 | 153,954,323 | RGD:6480464 | CTD | |
| G | Mybpc2 | myosin binding protein C, fast-type |
|
affects expression | ISO | 1 | 94,979,308 | 95,002,804 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
multiple interactions | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
multiple interactions | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
affects expression | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
multiple interactions | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
multiple interactions | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
decreases expression | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
decreases expression | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
increases activity | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
increases expression | EXP | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Mycbp | c-myc binding protein |
|
increases expression | ISO | 5 | 143,196,136 | 143,203,083 | RGD:6480464 | CTD | |
| G | Myg1 | melanocyte proliferating gene 1 |
|
affects expression | ISO | 7 | 141,080,469 | 141,087,672 | RGD:6480464 | CTD | |
| G | Myh10 | myosin, heavy chain 10, non-muscle |
|
multiple interactions | ISO | 10 | 55,445,288 | 55,576,096 | RGD:6480464 | CTD | |
| G | Myh6 | myosin, heavy chain 6, cardiac muscle, alpha |
|
affects expression | ISO | 15 | 33,044,506 | 33,068,098 | RGD:6480464 | CTD | |
| G | Myh7 | myosin, heavy chain 7, cardiac muscle, beta |
|
affects expression | ISO | 15 | 33,072,928 | 33,094,595 | RGD:6480464 | CTD | |
| G | Myl1 | myosin, light chain 1 |
|
affects expression | ISO | 9 | 65,717,097 | 65,737,576 | RGD:6480464 | CTD | |
| G | Myl7 | myosin, light chain 7, regulatory |
|
affects expression | ISO | 14 | 86,568,142 | 86,570,122 | RGD:6480464 | CTD | |
| G | Myo18a | myosin XVIIIa |
|
affects expression | ISO | 10 | 63,818,690 | 63,906,414 | RGD:6480464 | CTD | |
| G | Myo1c | myosin IC |
|
affects expression | ISO | 10 | 62,990,673 | 63,006,974 | RGD:6480464 | CTD | |
| G | Myo5a | myosin VA |
|
increases expression | ISO | 8 | 79,909,224 | 80,027,290 | RGD:6480464 | CTD | |
| G | Myo5a | myosin VA |
|
multiple interactions | ISO | 8 | 79,909,224 | 80,027,290 | RGD:6480464 | CTD | |
| G | Myo7b | myosin VIIb |
|
affects expression | ISO | 18 | 24,382,252 | 24,463,999 | RGD:6480464 | CTD | |
| G | Myod1 | myogenic differentiation 1 |
|
decreases expression | ISO | 1 | 96,910,190 | 96,912,900 | RGD:6480464 | CTD | |
| G | Myoz2 | myozenin 2 |
|
affects expression | ISO | 2 | 219,702,470 | 219,729,176 | RGD:6480464 | CTD | |
| G | Myt1l | myelin transcription factor 1-like |
|
multiple interactions | ISO | 6 | 47,435,167 | 47,828,030 | RGD:6480464 | CTD | |
| G | N4bp2l1 | NEDD4 binding protein 2-like 1 |
|
affects expression | ISO | 12 | 4,256,571 | 4,280,941 | RGD:6480464 | CTD | |
| G | Nadk | NAD kinase |
|
decreases expression | ISO | 5 | 172,393,075 | 172,422,858 | RGD:6480464 | CTD | |
| G | Nav2 | neuron navigator 2 |
|
multiple interactions | ISO | 1 | 99,041,044 | 99,410,077 | RGD:6480464 | CTD | |
| G | Nav2 | neuron navigator 2 |
|
affects expression | ISO | 1 | 99,041,044 | 99,410,077 | RGD:6480464 | CTD | |
| G | Nelfe | negative elongation factor complex member E |
|
increases expression | ISO | 20 | 4,077,925 | 4,081,561 | RGD:6480464 | CTD | |
| G | Nkd1 | naked cuticle homolog 1 (Drosophila) |
|
increases expression | ISO | 19 | 19,759,537 | 19,832,877 | RGD:6480464 | CTD | |
| G | Nkiras2 | NFKB inhibitor interacting Ras-like 2 |
|
affects expression | ISO | 10 | 89,567,630 | 89,571,657 | RGD:6480464 | CTD | |
| G | Nlrp3 | NLR family, pyrin domain containing 3 |
|
multiple interactions | ISO | 10 | 45,850,224 | 45,874,533 | RGD:6480464 | CTD | |
| G | Nme1 | NME/NM23 nucleoside diphosphate kinase 1 |
|
affects expression | ISO | 10 | 82,591,705 | 82,601,075 | RGD:6480464 | CTD | |
| G | Nme6 | NME/NM23 nucleoside diphosphate kinase 6 |
|
affects expression | ISO | 8 | 114,205,773 | 114,212,486 | RGD:6480464 | CTD | |
| G | Nmi | N-myc (and STAT) interactor |
|
affects expression | ISO | 3 | 32,962,021 | 32,996,031 | RGD:6480464 | CTD | |
| G | Nnat | neuronatin |
|
affects expression | ISO | 3 | 148,269,404 | 148,271,781 | RGD:6480464 | CTD | |
| G | Nnmt | nicotinamide N-methyltransferase |
|
multiple interactions | ISO | 8 | 51,871,506 | 51,883,785 | RGD:6480464 | CTD | |
| G | Nnmt | nicotinamide N-methyltransferase |
|
affects expression | ISO | 8 | 51,871,506 | 51,883,785 | RGD:6480464 | CTD | |
| G | Nnmt | nicotinamide N-methyltransferase |
|
affects expression | ISO | 8 | 51,871,506 | 51,883,785 | RGD:6480464 | CTD | |
| G | Noa1 | nitric oxide associated 1 |
|
increases activity | ISO | 14 | 33,107,963 | 33,123,993 | RGD:6480464 | CTD | |
| G | Noa1 | nitric oxide associated 1 |
|
multiple interactions | EXP | 14 | 33,107,963 | 33,123,993 | RGD:6480464 | CTD | |
| G | Noa1 | nitric oxide associated 1 |
|
increases activity | EXP | 14 | 33,107,963 | 33,123,993 | RGD:6480464 | CTD | |
| G | Nomo1 | nodal modulator 1 |
|
affects expression | ISO | 1 | 96,528,675 | 96,579,476 | RGD:6480464 | CTD | |
| G | Nos1 | nitric oxide synthase 1, neuronal |
|
multiple interactions | EXP | 12 | 39,812,500 | 39,869,484 | RGD:6480464 | CTD | |
| G | Nos2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 10 | 65,036,884 | 65,072,453 | RGD:6480464 | CTD | |
| G | Nos2 | nitric oxide synthase 2, inducible |
|
increases expression | ISO | 10 | 65,036,884 | 65,072,453 | RGD:6480464 | CTD | |
| G | Nos2 | nitric oxide synthase 2, inducible |
|
decreases expression | ISO | 10 | 65,036,884 | 65,072,453 | RGD:6480464 | CTD | |
| G | Nos2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 10 | 65,036,884 | 65,072,453 | RGD:6480464 | CTD | |
| G | Nos3 | nitric oxide synthase 3, endothelial cell |
|
multiple interactions | ISO | 4 | 6,158,847 | 6,179,441 | RGD:6480464 | CTD | |
| G | Notch1 | notch 1 |
|
decreases expression | EXP | 3 | 4,631,797 | 4,677,640 | RGD:6480464 | CTD | |
| G | Notch1 | notch 1 |
|
multiple interactions | EXP | 3 | 4,631,797 | 4,677,640 | RGD:6480464 | CTD | |
| G | Notch3 | notch 3 |
|
affects expression | ISO | 7 | 12,688,267 | 12,740,015 | RGD:6480464 | CTD | |
| G | Nov | nephroblastoma overexpressed |
|
multiple interactions | ISO | 7 | 91,162,676 | 91,169,696 | RGD:6480464 | CTD | |
| G | Nova1 | neuro-oncological ventral antigen 1 |
|
decreases expression | ISO | 6 | 66,193,472 | 66,320,240 | RGD:6480464 | CTD | |
| G | Npm3 | nucleophosmin/nucleoplasmin, 3 |
|
affects expression | ISO | 1 | 250,961,968 | 250,963,813 | RGD:6480464 | CTD | |
| G | Npr2 | natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
|
affects expression | ISO | 5 | 60,107,563 | 60,127,960 | RGD:6480464 | CTD | |
| G | Npr2 | natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
|
multiple interactions | ISO | 5 | 60,107,563 | 60,127,960 | RGD:6480464 | CTD | |
| G | Npy1r | neuropeptide Y receptor Y1 |
|
affects expression | ISO | 16 | 24,747,183 | 24,756,507 | RGD:6480464 | CTD | |
| G | Nqo1 | NAD(P)H dehydrogenase, quinone 1 |
|
affects expression | ISO | 19 | 37,251,147 | 37,266,040 | RGD:6480464 | CTD | |
| G | Nr0b2 | nuclear receptor subfamily 0, group B, member 2 |
|
increases expression | ISO | 5 | 151,524,685 | 151,528,000 | RGD:6480464 | CTD | |
| G | Nr0b2 | nuclear receptor subfamily 0, group B, member 2 |
|
affects expression | ISO | 5 | 151,524,685 | 151,528,000 | RGD:6480464 | CTD | |
| G | Nr0b2 | nuclear receptor subfamily 0, group B, member 2 |
|
increases expression | ISO | 5 | 151,524,685 | 151,528,000 | RGD:6480464 | CTD | |
| G | Nr1d1 | nuclear receptor subfamily 1, group D, member 1 |
|
multiple interactions | ISO | 10 | 87,541,246 | 87,548,186 | RGD:6480464 | CTD | |
| G | Nr1d1 | nuclear receptor subfamily 1, group D, member 1 |
|
affects expression | ISO | 10 | 87,541,246 | 87,548,186 | RGD:6480464 | CTD | |
| G | Nr1d2 | nuclear receptor subfamily 1, group D, member 2 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Nr1i2 | nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions | ISO | 11 | 64,239,918 | 64,276,702 | RGD:6480464 | CTD | |
| G | Nr1i2 | nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions | ISO | 11 | 64,239,918 | 64,276,702 | RGD:6480464 | CTD | |
| G | Nr1i2 | nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions | ISO | 11 | 64,239,918 | 64,276,702 | RGD:6480464 | CTD | |
| G | Nr1i2 | nuclear receptor subfamily 1, group I, member 2 |
|
increases activity | ISO | 11 | 64,239,918 | 64,276,702 | RGD:6480464 | CTD | |
| G | Nr1i3 | nuclear receptor subfamily 1, group I, member 3 |
|
affects expression | ISO | 13 | 87,104,241 | 87,108,563 | RGD:6480464 | CTD | |
| G | Nr2f1 | nuclear receptor subfamily 2, group F, member 1 |
|
decreases activity | ISO | 2 | 5,765,399 | 5,794,104 | RGD:6480464 | CTD | |
| G | Nr2f6 | nuclear receptor subfamily 2, group F, member 6 |
|
multiple interactions | ISO | 16 | 18,535,181 | 18,542,627 | RGD:6480464 | CTD | |
| G | Nr3c1 | nuclear receptor subfamily 3, group C, member 1 |
|
affects expression | ISO | 18 | 32,371,496 | 32,459,145 | RGD:6480464 | CTD | |
| G | Nr3c1 | nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions | ISO | 18 | 32,371,496 | 32,459,145 | RGD:6480464 | CTD | |
| G | Nr4a1 | nuclear receptor subfamily 4, group A, member 1 |
|
affects expression | ISO | 7 | 140,012,807 | 140,020,590 | RGD:6480464 | CTD | |
| G | Nr4a3 | nuclear receptor subfamily 4, group A, member 3 |
|
multiple interactions | ISO | 5 | 64,713,468 | 64,753,311 | RGD:6480464 | CTD | |
| G | Nr5a1 | nuclear receptor subfamily 5, group A, member 1 |
|
increases activity | ISO | 3 | 18,498,913 | 18,519,738 | RGD:6480464 | CTD | |
| G | Nr5a1 | nuclear receptor subfamily 5, group A, member 1 |
|
increases phosphorylation | ISO | 3 | 18,498,913 | 18,519,738 | RGD:6480464 | CTD | |
| G | Nradd | neurotrophin receptor associated death domain |
|
affects expression | ISO | 8 | 115,002,319 | 115,005,292 | RGD:6480464 | CTD | |
| G | Nrbp | nuclear receptor binding protein | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Nrbp2 | nuclear receptor binding protein 2 |
|
affects expression | ISO | 7 | 114,117,884 | 114,123,617 | RGD:6480464 | CTD | |
| G | Nrep | neuronal regeneration related protein |
|
affects expression | ISO | 18 | 25,842,127 | 25,868,219 | RGD:6480464 | CTD | |
| G | Nrg4 | neuregulin 4 |
|
affects expression | ISO | 8 | 58,764,526 | 58,830,666 | RGD:6480464 | CTD | |
| G | Nrm | nurim (nuclear envelope membrane protein) |
|
affects expression | ISO | 20 | 3,035,770 | 3,039,251 | RGD:6480464 | CTD | |
| G | Nrp1 | neuropilin 1 |
|
affects expression | ISO | 19 | 58,332,004 | 58,487,686 | RGD:6480464 | CTD | |
| G | Nsg2 | neuron specific gene family member 2 |
|
affects expression | ISO | 10 | 15,849,138 | 15,909,029 | RGD:6480464 | CTD | |
| G | Nsun6 | NOP2/Sun domain family, member 6 |
|
affects expression | ISO | 17 | 89,082,141 | 89,120,005 | RGD:6480464 | CTD | |
| G | Os9 | osteosarcoma amplified 9 |
|
affects expression | ISO | 7 | 67,046,802 | 67,073,355 | RGD:6480464 | CTD | |
| G | Pbld2 | phenazine biosynthesis-like protein domain containing 2 |
|
affects expression | ISO | 20 | 25,379,865 | 25,410,260 | RGD:6480464 | CTD | |
| G | Pc | pyruvate carboxylase |
|
affects expression | ISO | 1 | 207,112,853 | 207,212,737 | RGD:6480464 | CTD | |
| G | Pctp | phosphatidylcholine transfer protein |
|
multiple interactions | ISO | 10 | 78,400,328 | 78,420,774 | RGD:6480464 | CTD | |
| G | Pdcd1 | programmed cell death 1 |
|
affects expression | ISO | 9 | 93,172,543 | 93,185,687 | RGD:6480464 | CTD | |
| G | Pdcd2 | programmed cell death 2 |
|
affects expression | ISO | 1 | 54,412,081 | 54,417,571 | RGD:6480464 | CTD | |
| G | Pde2a | phosphodiesterase 2A, cGMP-stimulated |
|
affects expression | ISO | 1 | 158,921,607 | 159,013,829 | RGD:6480464 | CTD | |
| G | Pde4b | phosphodiesterase 4B, cAMP specific |
|
affects expression | ISO | 5 | 123,158,156 | 123,533,877 | RGD:6480464 | CTD | |
| G | Pde4b | phosphodiesterase 4B, cAMP specific |
|
affects expression | ISO | 5 | 123,158,156 | 123,533,877 | RGD:6480464 | CTD | |
| G | Pde9a | phosphodiesterase 9A |
|
affects expression | ISO | 20 | 9,806,117 | 9,901,584 | RGD:6480464 | CTD | |
| G | Pdgfa | platelet-derived growth factor alpha polypeptide |
|
affects expression | ISO | 12 | 16,151,045 | 16,172,412 | RGD:6480464 | CTD | |
| G | Pdia4 | protein disulfide isomerase family A, member 4 |
|
affects expression | ISO | 4 | 75,929,398 | 75,948,299 | RGD:6480464 | CTD | |
| G | Pdk2 | pyruvate dehydrogenase kinase, isozyme 2 |
|
affects expression | ISO | 10 | 83,710,448 | 83,724,973 | RGD:6480464 | CTD | |
| G | Pdk4 | pyruvate dehydrogenase kinase, isozyme 4 |
|
affects expression | ISO | 4 | 30,235,296 | 30,245,298 | RGD:6480464 | CTD | |
| G | Pdlim1 | PDZ and LIM domain 1 |
|
affects expression | ISO | 1 | 245,350,086 | 245,399,534 | RGD:6480464 | CTD | |
| G | Pdlim2 | PDZ and LIM domain 2 |
|
affects expression | ISO | 15 | 50,564,108 | 50,575,871 | RGD:6480464 | CTD | |
| G | Pdlim3 | PDZ and LIM domain 3 |
|
multiple interactions | ISO | 16 | 49,637,068 | 49,668,802 | RGD:6480464 | CTD | |
| G | Pdp1 | pyruvate dehyrogenase phosphatase catalytic subunit 1 |
|
multiple interactions | ISO | 5 | 26,234,414 | 26,240,301 | RGD:6480464 | CTD | |
| G | Pdxdc1 | pyridoxal-dependent decarboxylase domain containing 1 |
|
affects expression | ISO | 10 | 1,543,542 | 1,637,788 | RGD:6480464 | CTD | |
| G | Pdxk | pyridoxal (pyridoxine, vitamin B6) kinase |
|
affects expression | ISO | 20 | 10,541,656 | 10,563,199 | RGD:6480464 | CTD | |
| G | Pecr | peroxisomal trans-2-enoyl-CoA reductase |
|
affects expression | ISO | 9 | 71,414,826 | 71,443,719 | RGD:6480464 | CTD | |
| G | Pemt | phosphatidylethanolamine N-methyltransferase | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Penk | proenkephalin |
|
affects expression | ISO | 5 | 17,509,323 | 17,514,265 | RGD:6480464 | CTD | |
| G | Pepd | peptidase D |
|
affects expression | ISO | 1 | 87,421,576 | 87,547,908 | RGD:6480464 | CTD | |
| G | Per1 | period circadian clock 1 |
|
affects expression | ISO | 10 | 55,859,851 | 55,868,747 | RGD:6480464 | CTD | |
| G | Pex1 | peroxisomal biogenesis factor 1 |
|
affects expression | ISO | 4 | 27,235,147 | 27,275,076 | RGD:6480464 | CTD | |
| G | Pfdn5 | prefoldin subunit 5 |
|
affects expression | ISO | 7 | 141,075,469 | 141,080,207 | RGD:6480464 | CTD | |
| G | Pfkfb3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
affects expression | ISO | 17 | 78,241,182 | 78,268,272 | RGD:6480464 | CTD | |
| G | Pfkfb3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
multiple interactions | ISO | 17 | 78,241,182 | 78,268,272 | RGD:6480464 | CTD | |
| G | Pfn2 | profilin 2 |
|
affects expression | ISO | 2 | 147,066,815 | 147,072,519 | RGD:6480464 | CTD | |
| G | Pgap2 | post-GPI attachment to proteins 2 |
|
affects expression | ISO | 1 | 159,696,924 | 159,722,582 | RGD:6480464 | CTD | |
| G | Pgc | progastricsin (pepsinogen C) |
|
decreases expression | ISO | 9 | 8,723,620 | 8,731,837 | RGD:6480464 | CTD | |
| G | Pgd | phosphogluconate dehydrogenase | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Pgf | placental growth factor |
|
affects expression | ISO | 6 | 109,215,540 | 109,226,122 | RGD:6480464 | CTD | |
| G | Pggt1b | protein geranylgeranyltransferase type I, beta subunit |
|
increases expression | ISO | 18 | 40,410,055 | 40,452,883 | RGD:6480464 | CTD | |
| G | Pgk1 | phosphoglycerate kinase 1 |
|
increases expression | EXP | X | 94,324,219 | 94,340,193 | RGD:6480464 | CTD | |
| G | Pgk1 | phosphoglycerate kinase 1 |
|
increases expression | ISO | X | 94,324,219 | 94,340,193 | RGD:6480464 | CTD | |
| G | Pgpep1 | pyroglutamyl-peptidase I |
|
affects expression | ISO | 16 | 19,276,650 | 19,285,828 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
affects response to substance | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases response to substance | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
decreases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
decreases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | EXP | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | EXP | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | EXP | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | EXP | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgrmc1 | progesterone receptor membrane component 1 |
|
affects expression | ISO | X | 8,265,543 | 8,273,667 | RGD:6480464 | CTD | |
| G | Pgrmc2 | progesterone receptor membrane component 2 |
|
affects expression | ISO | 2 | 128,025,076 | 128,040,975 | RGD:6480464 | CTD | |
| G | Pgs1 | phosphatidylglycerophosphate synthase 1 |
|
affects expression | ISO | 10 | 107,978,636 | 108,009,997 | RGD:6480464 | CTD | |
| G | Phb | prohibitin | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Phb2 | prohibitin 2 |
|
multiple interactions | ISO | 4 | 160,835,328 | 160,839,933 | RGD:6480464 | CTD | |
| G | Phb2 | prohibitin 2 |
|
affects expression | ISO | 4 | 160,835,328 | 160,839,933 | RGD:6480464 | CTD | |
| G | Phc2 | polyhomeotic homolog 2 (Drosophila) |
|
multiple interactions | ISO | 5 | 147,930,703 | 147,978,856 | RGD:6480464 | CTD | |
| G | Phc2 | polyhomeotic homolog 2 (Drosophila) |
|
affects expression | ISO | 5 | 147,930,703 | 147,978,856 | RGD:6480464 | CTD | |
| G | Phf11 | PHD finger protein 11 |
|
multiple interactions | ISO | 15 | 38,443,971 | 38,477,944 | RGD:6480464 | CTD | |
| G | Phf23 | PHD finger protein 23 |
|
affects expression | ISO | 10 | 56,841,624 | 56,846,146 | RGD:6480464 | CTD | |
| G | Phf5a | PHD finger protein 5A |
|
affects expression | ISO | 7 | 120,216,581 | 120,223,146 | RGD:6480464 | CTD | |
| G | Phf7 | PHD finger protein 7 |
|
affects expression | ISO | 16 | 6,671,312 | 6,684,015 | RGD:6480464 | CTD | |
| G | Pkn3 | protein kinase N3 |
|
affects expression | ISO | 3 | 9,068,176 | 9,096,114 | RGD:6480464 | CTD | |
| G | Plekhm2 | pleckstrin homology domain containing, family M (with RUN domain) member 2 |
|
increases expression | ISO | 5 | 160,527,710 | 160,565,407 | RGD:6480464 | CTD | |
| G | Plin4 | perilipin 4 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Pnkd | paroxysmal nonkinesigenic dyskinesia |
|
affects expression | ISO | 9 | 73,611,610 | 73,697,690 | RGD:6480464 | CTD | |
| G | Ppcs | phosphopantothenoylcysteine synthetase |
|
affects expression | ISO | 5 | 140,008,434 | 140,012,295 | RGD:6480464 | CTD | |
| G | Pphln1 | periphilin 1 |
|
affects expression | ISO | 7 | 131,866,854 | 131,958,060 | RGD:6480464 | CTD | |
| G | Ppia | peptidylprolyl isomerase A (cyclophilin A) |
|
decreases expression | ISO | 14 | 87,165,998 | 87,169,995 | RGD:6480464 | CTD | |
| G | Ppia | peptidylprolyl isomerase A (cyclophilin A) |
|
multiple interactions | ISO | 14 | 87,165,998 | 87,169,995 | RGD:6480464 | CTD | |
| G | Ppih | peptidylprolyl isomerase H (cyclophilin H) |
|
affects expression | ISO | 5 | 139,959,365 | 139,969,320 | RGD:6480464 | CTD | |
| G | Ppil2 | peptidylprolyl isomerase (cyclophilin)-like 2 |
|
affects expression | ISO | 11 | 85,903,199 | 85,925,790 | RGD:6480464 | CTD | |
| G | Ppm1a | protein phosphatase, Mg2+/Mn2+ dependent, 1A |
|
affects expression | ISO | 6 | 95,162,067 | 95,198,936 | RGD:6480464 | CTD | |
| G | Ppm1b | protein phosphatase, Mg2+/Mn2+ dependent, 1B |
|
affects expression | ISO | 6 | 8,319,544 | 8,373,795 | RGD:6480464 | CTD | |
| G | Ppm1g | protein phosphatase, Mg2+/Mn2+ dependent, 1G |
|
affects expression | ISO | 6 | 25,145,569 | 25,149,811 | RGD:6480464 | CTD | |
| G | Ppp1r10 | protein phosphatase 1, regulatory subunit 10 |
|
affects expression | ISO | 20 | 2,940,605 | 2,984,636 | RGD:6480464 | CTD | |
| G | Ppp1r12b | protein phosphatase 1, regulatory subunit 12B |
|
affects expression | ISO | 13 | 47,705,569 | 47,917,673 | RGD:6480464 | CTD | |
| G | Ppp1r13b | protein phosphatase 1, regulatory subunit 13B |
|
affects expression | ISO | 6 | 136,620,379 | 136,659,341 | RGD:6480464 | CTD | |
| G | Ppp1r15b | protein phosphatase 1, regulatory subunit 15B |
|
affects expression | ISO | 13 | 46,039,831 | 46,047,636 | RGD:6480464 | CTD | |
| G | Ppp1r3c | protein phosphatase 1, regulatory subunit 3C |
|
affects expression | ISO | 1 | 240,991,884 | 240,996,887 | RGD:6480464 | CTD | |
| G | Ppp1r8 | protein phosphatase 1, regulatory subunit 8 |
|
affects expression | ISO | 5 | 152,305,936 | 152,323,075 | RGD:6480464 | CTD | |
| G | Ppp2ca | protein phosphatase 2, catalytic subunit, alpha isozyme |
|
decreases expression | ISO | 10 | 37,621,256 | 37,641,008 | RGD:6480464 | CTD | |
| G | Ppp2r5e | protein phosphatase 2, regulatory subunit B', epsilon isoform |
|
affects expression | ISO | 6 | 98,047,316 | 98,197,549 | RGD:6480464 | CTD | |
| G | Ppp3r1 | protein phosphatase 3, regulatory subunit B, alpha |
|
affects expression | ISO | 14 | 98,060,302 | 98,099,092 | RGD:6480464 | CTD | |
| G | Ppp4r1 | protein phosphatase 4, regulatory subunit 1 |
|
affects expression | ISO | 9 | 104,572,704 | 104,611,601 | RGD:6480464 | CTD | |
| G | Ppp5c | protein phosphatase 5, catalytic subunit |
|
decreases expression | ISO | 1 | 77,345,194 | 77,369,417 | RGD:6480464 | CTD | |
| G | Ppt1 | palmitoyl-protein thioesterase 1 |
|
affects expression | ISO | 5 | 142,153,498 | 142,173,401 | RGD:6480464 | CTD | |
| G | Pptc7 | PTC7 protein phosphatase homolog (S. cerevisiae) |
|
affects expression | ISO | 12 | 35,445,302 | 35,483,671 | RGD:6480464 | CTD | |
| G | Pqbp1 | polyglutamine binding protein 1 |
|
affects expression | ISO | X | 26,638,460 | 26,642,640 | RGD:6480464 | CTD | |
| G | Prap1 | proline-rich acidic protein 1 |
|
affects expression | ISO | 1 | 199,889,629 | 199,893,425 | RGD:6480464 | CTD | |
| G | Prdx3 | peroxiredoxin 3 |
|
affects expression | ISO | 1 | 267,468,371 | 267,481,273 | RGD:6480464 | CTD | |
| G | Prdx3 | peroxiredoxin 3 |
|
affects expression | ISO | 1 | 267,468,371 | 267,481,273 | RGD:6480464 | CTD | |
| G | Prep | prolyl endopeptidase |
|
affects expression | ISO | 20 | 49,024,917 | 49,144,670 | RGD:6480464 | CTD | |
| G | Prf1 | perforin 1 (pore forming protein) |
|
decreases expression | ISO | 20 | 28,658,367 | 28,663,877 | RGD:6480464 | CTD | |
| G | Prf1 | perforin 1 (pore forming protein) |
|
increases expression | ISO | 20 | 28,658,367 | 28,663,877 | RGD:6480464 | CTD | |
| G | Prickle3 | prickle homolog 3 (Drosophila) |
|
affects expression | ISO | X | 26,878,508 | 26,889,077 | RGD:6480464 | CTD | |
| G | Prkacb | protein kinase, cAMP dependent, catalytic, beta |
|
affects expression | ISO | 2 | 244,949,303 | 245,035,266 | RGD:6480464 | CTD | |
| G | Prkar1a | protein kinase, cAMP-dependent, regulatory, type I, alpha |
|
affects expression | ISO | 10 | 148,642,200 | 148,642,454 | RGD:6480464 | CTD | |
| G | Prkar1b | protein kinase, cAMP dependent regulatory, type I, beta |
|
affects expression | ISO | 12 | 16,025,867 | 16,131,129 | RGD:6480464 | CTD | |
| G | Prkca | protein kinase C, alpha |
|
affects expression | ISO | 10 | 97,367,196 | 97,638,910 | RGD:6480464 | CTD | |
| G | Prkca | protein kinase C, alpha |
|
decreases phosphorylation | ISO | 10 | 97,367,196 | 97,638,910 | RGD:6480464 | CTD | |
| G | Prkcd | protein kinase C, delta |
|
decreases phosphorylation | ISO | 16 | 5,954,218 | 5,975,743 | RGD:6480464 | CTD | |
| G | Prkcdbp | protein kinase C, delta binding protein |
|
affects expression | ISO | 1 | 163,212,922 | 163,214,511 | RGD:6480464 | CTD | |
| G | Prkce | protein kinase C, epsilon |
|
affects localization | ISO | 6 | 9,631,234 | 10,097,311 | RGD:6480464 | CTD | |
| G | Prkcz | protein kinase C, zeta |
|
multiple interactions | ISO | 5 | 172,061,825 | 172,172,793 | RGD:6480464 | CTD | |
| G | Prkd3 | protein kinase D3 |
|
affects expression | ISO | 6 | 1,727,315 | 1,796,290 | RGD:6480464 | CTD | |
| G | Prkg1 | protein kinase, cGMP-dependent, type 1 |
|
affects expression | ISO | 1 | 234,420,597 | 235,765,375 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
affects expression | ISO | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
decreases secretion | ISO | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
increases expression | ISO | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl6a1 | prolactin family 6, subfamily a, member 1 |
|
affects expression | ISO | 17 | 44,267,690 | 44,272,479 | RGD:6480464 | CTD | |
| G | Prm3 | protamine 3 |
|
affects expression | ISO | 10 | 4,814,767 | 4,815,281 | RGD:6480464 | CTD | |
| G | Prmt7 | protein arginine methyltransferase 7 |
|
affects expression | ISO | 19 | 36,059,837 | 36,111,356 | RGD:6480464 | CTD | |
| G | Proc | protein C |
|
decreases expression | ISO | 18 | 24,563,368 | 24,573,715 | RGD:6480464 | CTD | |
| G | Pros1 | protein S (alpha) | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Pros1 | protein S (alpha) | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Prpf31 | PRP31 pre-mRNA processing factor 31 homolog (S. cerevisiae) |
|
affects expression | ISO | 1 | 63,888,815 | 63,900,490 | RGD:6480464 | CTD | |
| G | Prpf38a | PRP38 pre-mRNA processing factor 38 (yeast) domain containing A |
|
affects expression | ISO | 5 | 129,866,098 | 129,877,797 | RGD:6480464 | CTD | |
| G | Prpf40a | PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) |
|
affects expression | ISO | 3 | 34,661,461 | 34,721,438 | RGD:6480464 | CTD | |
| G | Prpf4b | PRP4 pre-mRNA processing factor 4 homolog B (yeast) |
|
increases expression | ISO | 17 | 36,319,606 | 36,350,616 | RGD:6480464 | CTD | |
| G | Prpf4b | PRP4 pre-mRNA processing factor 4 homolog B (yeast) |
|
affects expression | ISO | 17 | 36,319,606 | 36,350,616 | RGD:6480464 | CTD | |
| G | Prpf8 | PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae) |
|
affects expression | ISO | 10 | 62,786,225 | 62,830,939 | RGD:6480464 | CTD | |
| G | Prps1 | phosphoribosyl pyrophosphate synthetase 1 |
|
affects expression | ISO | X | 128,249,843 | 128,271,893 | RGD:6480464 | CTD | |
| G | Prps1l1 | phosphoribosyl pyrophosphate synthetase 1-like 1 |
|
decreases expression | ISO | 6 | 53,652,048 | 53,653,738 | RGD:6480464 | CTD | |
| G | Prss2 | protease, serine, 2 |
|
affects expression | ISO | 4 | 69,088,288 | 69,093,312 | RGD:6480464 | CTD | |
| G | Prss29 | protease, serine, 29 |
|
affects expression | ISO | 10 | 14,569,722 | 14,571,558 | RGD:6480464 | CTD | |
| G | Psap | prosaposin |
|
affects expression | ISO | 20 | 27,595,048 | 27,621,574 | RGD:6480464 | CTD | |
| G | Psd3 | pleckstrin and Sec7 domain containing 3 |
|
affects expression | ISO | 16 | 23,194,137 | 23,662,010 | RGD:6480464 | CTD | |
| G | Rab40c | Rab40c, member RAS oncogene family |
|
increases expression | ISO | 10 | 15,147,861 | 15,181,653 | RGD:6480464 | CTD | |
| G | Rab5a | RAB5A, member RAS oncogene family |
|
affects expression | ISO | 9 | 1,492,864 | 1,516,405 | RGD:6480464 | CTD | |
| G | Rab5al1 | Rab5a, member RAS oncogene family-like 1 |
|
affects expression | ISO | 14 | 73,512,120 | 73,515,650 | RGD:6480464 | CTD | |
| G | Rabggtb | Rab geranylgeranyltransferase, beta subunit |
|
affects expression | ISO | 2 | 251,852,549 | 251,857,811 | RGD:6480464 | CTD | |
| G | Racgap1 | Rac GTPase-activating protein 1 |
|
affects expression | ISO | 7 | 138,366,356 | 138,395,716 | RGD:6480464 | CTD | |
| G | Rad51 | RAD51 homolog (S. cerevisiae) |
|
decreases expression | EXP | 3 | 105,625,265 | 105,650,392 | RGD:6480464 | CTD | |
| G | Rad51ap1 | RAD51 associated protein 1 |
|
affects expression | ISO | 4 | 163,308,788 | 163,321,854 | RGD:6480464 | CTD | |
| G | Rad51b | RAD51 homolog B (S. cerevisiae) |
|
affects expression | ISO | 6 | 102,069,799 | 102,134,176 | RGD:6480464 | CTD | |
| G | Ralgapa1 | Ral GTPase activating protein, alpha subunit 1 (catalytic) |
|
affects expression | ISO | 6 | 75,849,629 | 76,163,553 | RGD:6480464 | CTD | |
| G | Ralgds | ral guanine nucleotide dissociation stimulator |
|
affects expression | ISO | 3 | 7,516,054 | 7,537,651 | RGD:6480464 | CTD | |
| G | Ralgps1 | Ral GEF with PH domain and SH3 binding motif 1 |
|
affects expression | ISO | 3 | 12,146,421 | 12,379,365 | RGD:6480464 | CTD | |
| G | Ramp1 | receptor (G protein-coupled) activity modifying protein 1 |
|
affects expression | ISO | 9 | 90,402,493 | 90,450,038 | RGD:6480464 | CTD | |
| G | Ran | RAN, member RAS oncogene family |
|
increases expression | ISO | 12 | 28,736,786 | 28,739,921 | RGD:6480464 | CTD | |
| G | Ran | RAN, member RAS oncogene family |
|
increases expression | EXP | 12 | 28,736,786 | 28,739,921 | RGD:6480464 | CTD | |
| G | Ranbp1 | RAN binding protein 1 |
|
affects expression | ISO | 11 | 84,736,402 | 84,744,635 | RGD:6480464 | CTD | |
| G | Rangap1 | RAN GTPase activating protein 1 |
|
affects expression | ISO | 7 | 120,056,065 | 120,080,018 | RGD:6480464 | CTD | |
| G | Rapsn | receptor-associated protein of the synapse |
|
affects expression | ISO | 3 | 75,396,836 | 75,406,115 | RGD:6480464 | CTD | |
| G | Rara | retinoic acid receptor, alpha |
|
affects expression | ISO | 10 | 87,740,479 | 87,753,265 | RGD:6480464 | CTD | |
| G | Rars | arginyl-tRNA synthetase |
|
affects expression | ISO | 10 | 20,721,170 | 20,745,484 | RGD:6480464 | CTD | |
| G | Rasa1 | RAS p21 protein activator (GTPase activating protein) 1 |
|
affects expression | ISO | 2 | 14,203,815 | 14,287,824 | RGD:6480464 | CTD | |
| G | Rasa2 | RAS p21 protein activator 2 |
|
affects expression | ISO | 8 | 101,616,850 | 101,734,769 | RGD:6480464 | CTD | |
| G | Rasa4 | RAS p21 protein activator 4 |
|
affects expression | ISO | 12 | 21,668,173 | 21,695,505 | RGD:6480464 | CTD | |
| G | Rasgrp1 | RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
|
multiple interactions | ISO | 3 | 103,371,879 | 103,433,010 | RGD:6480464 | CTD | |
| G | Rasip1 | Ras interacting protein 1 |
|
affects expression | ISO | 1 | 96,097,668 | 96,108,543 | RGD:6480464 | CTD | |
| G | Rasl11b | RAS-like family 11 member B |
|
affects expression | ISO | 14 | 36,392,945 | 36,397,168 | RGD:6480464 | CTD | |
| G | Rassf1 | Ras association (RalGDS/AF-6) domain family member 1 |
|
affects expression | ISO | 8 | 112,798,863 | 112,810,004 | RGD:6480464 | CTD | |
| G | Rassf5 | Ras association (RalGDS/AF-6) domain family member 5 |
|
affects expression | ISO | 13 | 44,121,863 | 44,188,493 | RGD:6480464 | CTD | |
| G | Rassf7 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
|
affects expression | ISO | 1 | 201,411,162 | 201,413,083 | RGD:6480464 | CTD | |
| G | Rb1 | retinoblastoma 1 |
|
multiple interactions | ISO | 15 | 53,828,881 | 53,962,099 | RGD:6480464 | CTD | |
| G | Rb1 | retinoblastoma 1 |
|
multiple interactions | ISO | 15 | 53,828,881 | 53,962,099 | RGD:6480464 | CTD | |
| G | Rb1 | retinoblastoma 1 |
|
decreases phosphorylation | ISO | 15 | 53,828,881 | 53,962,099 | RGD:6480464 | CTD | |
| G | Rb1 | retinoblastoma 1 |
|
increases phosphorylation | ISO | 15 | 53,828,881 | 53,962,099 | RGD:6480464 | CTD | |
| G | Rb1 | retinoblastoma 1 |
|
decreases expression | EXP | 15 | 53,828,881 | 53,962,099 | RGD:6480464 | CTD | |
| G | Rb1 | retinoblastoma 1 |
|
multiple interactions | EXP | 15 | 53,828,881 | 53,962,099 | RGD:6480464 | CTD | |
| G | Rbbp6 | retinoblastoma binding protein 6 |
|
affects expression | ISO | 1 | 181,818,248 | 181,849,942 | RGD:6480464 | CTD | |
| G | Rbck1 | RanBP-type and C3HC4-type zinc finger containing 1 |
|
affects expression | ISO | 3 | 142,644,156 | 142,660,799 | RGD:6480464 | CTD | |
| G | Rbl1 | retinoblastoma-like 1 (p107) |
|
increases phosphorylation | ISO | 3 | 147,734,622 | 147,796,630 | RGD:6480464 | CTD | |
| G | Rbl2 | retinoblastoma-like 2 |
|
multiple interactions | ISO | 19 | 17,045,131 | 17,092,597 | RGD:6480464 | CTD | |
| G | Rbm17 | RNA binding motif protein 17 |
|
multiple interactions | ISO | 17 | 78,139,912 | 78,156,805 | RGD:6480464 | CTD | |
| G | Rbm3 | RNA binding motif (RNP1, RRM) protein 3 |
|
affects expression | ISO | X | 26,379,303 | 26,382,739 | RGD:6480464 | CTD | |
| G | Rbm39 | RNA binding motif protein 39 |
|
affects expression | ISO | 3 | 146,555,202 | 146,587,650 | RGD:6480464 | CTD | |
| G | Rbm8a | RNA binding motif protein 8A |
|
affects expression | ISO | 2 | 191,429,805 | 191,432,261 | RGD:6480464 | CTD | |
| G | Rbms3 | RNA binding motif, single stranded interacting protein 3 |
|
affects expression | ISO | 8 | 121,107,780 | 121,821,324 | RGD:6480464 | CTD | |
| G | Rbp4 | retinol binding protein 4, plasma |
|
affects expression | ISO | 1 | 242,443,795 | 242,450,997 | RGD:6480464 | CTD | |
| G | Rbpms | RNA binding protein with multiple splicing |
|
affects expression | ISO | 16 | 62,009,626 | 62,163,466 | RGD:6480464 | CTD | |
| G | Rbpms | RNA binding protein with multiple splicing |
|
affects expression | ISO | 16 | 62,009,626 | 62,163,466 | RGD:6480464 | CTD | |
| G | Rbx1 | ring-box 1, E3 ubiquitin protein ligase |
|
affects expression | ISO | 7 | 119,794,976 | 119,805,104 | RGD:6480464 | CTD | |
| G | Rcan2 | regulator of calcineurin 2 |
|
multiple interactions | ISO | 9 | 12,623,121 | 12,853,302 | RGD:6480464 | CTD | |
| G | Rcbtb2 | regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
|
affects expression | ISO | 15 | 53,789,994 | 53,819,842 | RGD:6480464 | CTD | |
| G | Rcor1 | REST corepressor 1 |
|
affects expression | ISO | 6 | 135,859,305 | 135,862,320 | RGD:6480464 | CTD | |
| G | Rdh10 | retinol dehydrogenase 10 (all-trans) |
|
affects expression | ISO | 5 | 2,286,373 | 2,314,154 | RGD:6480464 | CTD | |
| G | Reep3 | receptor accessory protein 3 |
|
affects expression | ISO | 20 | 22,314,093 | 22,397,087 | RGD:6480464 | CTD | |
| G | Rela | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | ISO | 1 | 208,262,669 | 208,273,148 | RGD:6480464 | CTD | |
| G | Rela | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | ISO | 1 | 208,262,669 | 208,273,148 | RGD:6480464 | CTD | |
| G | Rela | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | ISO | 1 | 208,262,669 | 208,273,148 | RGD:6480464 | CTD | |
| G | Rere | arginine-glutamic acid dipeptide (RE) repeats |
|
affects expression | ISO | 5 | 167,440,122 | 167,777,271 | RGD:6480464 | CTD | |
| G | Ret | ret proto-oncogene |
|
multiple interactions | ISO | 4 | 154,448,179 | 154,491,103 | RGD:6480464 | CTD | |
| G | Retnla | resistin like alpha |
|
affects expression | ISO | 11 | 53,205,246 | 53,206,745 | RGD:6480464 | CTD | |
| G | Rora | RAR-related orphan receptor A |
|
affects expression | ISO | 8 | 73,052,282 | 73,817,764 | RGD:6480464 | CTD | |
| G | Rora | RAR-related orphan receptor A |
|
decreases activity | ISO | 8 | 73,052,282 | 73,817,764 | RGD:6480464 | CTD | |
| G | Rps27l | ribosomal protein S27-like | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Rps27l2 | ribosomal protein S27-like 2 |
|
affects expression | ISO | 12 | 29,143,461 | 29,143,842 | RGD:6480464 | CTD | |
| G | Ryr1 | ryanodine receptor 1 (skeletal) |
|
affects expression | ISO | 1 | 84,116,098 | 84,254,503 | RGD:6480464 | CTD | |
| G | Sardh | sarcosine dehydrogenase |
|
affects expression | ISO | 3 | 6,076,166 | 6,142,565 | RGD:6480464 | CTD | |
| G | Sart1 | squamous cell carcinoma antigen recognized by T cells |
|
decreases expression | ISO | 1 | 208,026,619 | 208,035,281 | RGD:6480464 | CTD | |
| G | Satb1 | SATB homeobox 1 |
|
affects expression | ISO | 9 | 3,307,651 | 3,391,348 | RGD:6480464 | CTD | |
| G | Sav1 | salvador homolog 1 (Drosophila) |
|
affects expression | ISO | 6 | 92,081,608 | 92,101,975 | RGD:6480464 | CTD | |
| G | Sbk1 | SH3-binding domain kinase 1 |
|
affects expression | ISO | 1 | 185,344,267 | 185,366,109 | RGD:6480464 | CTD | |
| G | Scaf11 | SR-related CTD-associated factor 11 |
|
affects expression | ISO | 7 | 135,088,641 | 135,138,269 | RGD:6480464 | CTD | |
| G | Scara5 | scavenger receptor class A, member 5 (putative) |
|
affects expression | ISO | 15 | 45,083,644 | 45,189,211 | RGD:6480464 | CTD | |
| G | Scd1 | stearoyl-Coenzyme A desaturase 1 |
|
affects expression | ISO | 1 | 249,458,860 | 249,471,460 | RGD:6480464 | CTD | |
| G | Scd1 | stearoyl-Coenzyme A desaturase 1 |
|
decreases expression | EXP | 1 | 249,458,860 | 249,471,460 | RGD:6480464 | CTD | |
| G | Scg5 | secretogranin V (7B2 protein) |
|
affects expression | ISO | 3 | 99,629,194 | 99,674,523 | RGD:6480464 | CTD | |
| G | Scnn1a | sodium channel, nonvoltage-gated 1 alpha |
|
multiple interactions | ISO | 4 | 161,445,936 | 161,469,267 | RGD:6480464 | CTD | |
| G | Scp2 | sterol carrier protein 2 |
|
affects expression | ISO | 5 | 129,152,836 | 129,230,401 | RGD:6480464 | CTD | |
| G | Scpep1 | serine carboxypeptidase 1 |
|
affects expression | ISO | 10 | 77,347,473 | 77,377,945 | RGD:6480464 | CTD | |
| G | Scyl1 | SCY1-like 1 (S. cerevisiae) |
|
affects expression | ISO | 1 | 208,385,471 | 208,399,265 | RGD:6480464 | CTD | |
| G | Sdcbp | syndecan binding protein |
|
affects expression | ISO | 5 | 19,822,440 | 19,849,223 | RGD:6480464 | CTD | |
| G | Sdccag3 | serologically defined colon cancer antigen 3 |
|
affects expression | ISO | 3 | 4,554,201 | 4,557,651 | RGD:6480464 | CTD | |
| G | Sdf2l1 | stromal cell-derived factor 2-like 1 |
|
affects expression | ISO | 11 | 85,878,093 | 85,880,335 | RGD:6480464 | CTD | |
| G | Sdhb | succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
|
affects expression | ISO | 5 | 159,818,669 | 159,839,772 | RGD:6480464 | CTD | |
| G | Sds | serine dehydratase |
|
affects expression | ISO | 12 | 37,281,091 | 37,288,403 | RGD:6480464 | CTD | |
| G | Sec31a | SEC31 homolog A (S. cerevisiae) |
|
affects expression | ISO | 14 | 10,466,582 | 10,522,655 | RGD:6480464 | CTD | |
| G | Sec61a1 | Sec61 alpha 1 subunit (S. cerevisiae) |
|
affects expression | ISO | 4 | 122,597,889 | 122,612,245 | RGD:6480464 | CTD | |
| G | Sec63 | SEC63 homolog (S. cerevisiae) |
|
affects expression | ISO | 20 | 46,669,125 | 46,738,077 | RGD:6480464 | CTD | |
| G | Selenbp1 | selenium binding protein 1 |
|
affects expression | ISO | 2 | 189,840,450 | 189,881,332 | RGD:6480464 | CTD | |
| G | Sema3b | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
|
multiple interactions | ISO | 8 | 112,845,709 | 112,852,565 | RGD:6480464 | CTD | |
| G | Sema3c | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
|
affects expression | ISO | 4 | 13,739,659 | 13,914,636 | RGD:6480464 | CTD | |
| G | Sema3f | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3 F |
|
multiple interactions | ISO | 8 | 112,932,112 | 112,962,333 | RGD:6480464 | CTD | |
| G | Sema3f | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3 F |
|
affects expression | ISO | 8 | 112,932,112 | 112,962,333 | RGD:6480464 | CTD | |
| G | Sepp1 | selenoprotein P, plasma, 1 |
|
affects expression | ISO | 2 | 52,451,883 | 52,462,263 | RGD:6480464 | CTD | |
| G | Shb | Src homology 2 domain containing adaptor protein B |
|
affects expression | ISO | 5 | 61,983,643 | 62,090,620 | RGD:6480464 | CTD | |
| G | Sirt7 | sirtuin 7 |
|
decreases expression | ISO | 10 | 110,009,669 | 110,016,346 | RGD:6480464 | CTD | |
| G | Slc40a1 | solute carrier family 40 (iron-regulated transporter), member 1 |
|
affects expression | ISO | 9 | 44,977,430 | 44,995,358 | RGD:6480464 | CTD | |
| G | Slc44a2 | solute carrier family 44, member 2 |
|
affects expression | ISO | 8 | 20,433,914 | 20,451,580 | RGD:6480464 | CTD | |
| G | Snrpa1 | small nuclear ribonucleoprotein polypeptide A' |
|
affects expression | ISO | 1 | 120,490,921 | 120,503,974 | RGD:6480464 | CTD | |
| G | Snrpe | small nuclear ribonucleoprotein polypeptide E |
|
affects expression | ISO | 13 | 46,522,340 | 46,528,589 | RGD:6480464 | CTD | |
| G | Spint2 | serine peptidase inhibitor, Kunitz type, 2 |
|
affects expression | ISO | 1 | 84,393,845 | 84,416,299 | RGD:6480464 | CTD | |
| G | Spock2 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
|
affects expression | ISO | 20 | 27,397,527 | 27,425,914 | RGD:6480464 | CTD | |
| G | Stab1 | stabilin 1 |
|
increases expression | ISO | 16 | 6,567,583 | 6,597,972 | RGD:6480464 | CTD | |
| G | Sugp2 | SURP and G patch domain containing 2 |
|
affects expression | ISO | 16 | 19,644,374 | 19,673,741 | RGD:6480464 | CTD | |
| G | Tgfbi | transforming growth factor, beta induced |
|
multiple interactions | ISO | 17 | 13,904,882 | 13,935,110 | RGD:6480464 | CTD | |
| G | Thap2 | THAP domain containing, apoptosis associated protein 2 |
|
affects expression | ISO | 7 | 54,644,248 | 54,655,301 | RGD:6480464 | CTD | |
| G | Tiam2 | T-cell lymphoma invasion and metastasis 2 |
|
affects expression | ISO | 1 | 38,479,385 | 38,514,359 | RGD:6480464 | CTD | |
| G | Tpd52 | tumor protein D52 |
|
affects expression | ISO | 2 | 94,850,203 | 94,880,802 | RGD:6480464 | CTD | |
| G | Trim30 | tripartite motif-containing 30 |
|
affects expression | ISO | 1 | 162,173,035 | 162,184,423 | RGD:6480464 | CTD | |
| G | Trim6 | tripartite motif containing 6 |
|
affects expression | ISO | 1 | 162,059,220 | 162,094,672 | RGD:6480464 | CTD | |
| G | Ube2h | ubiquitin-conjugating enzyme E2H |
|
affects expression | ISO | 4 | 57,121,159 | 57,216,956 | RGD:6480464 | CTD | |
| G | Uqcrb | ubiquinol-cytochrome c reductase binding protein |
|
affects expression | ISO | 7 | 67,958,363 | 67,963,730 | RGD:6480464 | CTD | |
| G | Wsb1 | WD repeat and SOCS box-containing 1 |
|
affects expression | ISO | 10 | 65,427,131 | 65,443,208 | RGD:6480464 | CTD | |
| G | Wtap | Wilms tumor 1 associated protein |
|
increases expression | ISO | 1 | 41,891,437 | 41,917,254 | RGD:6480464 | CTD | |
| G | Zfp395 | zinc finger protein 395 |
|
multiple interactions | ISO | 15 | 44,806,300 | 44,819,787 | RGD:6480464 | CTD | |
Term paths to the root
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term